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ABSTRACT OF DISSERTATION

ENHANCING DRUG OVERDOSE MORTALITY SURVEILLANCE THROUGH
NATURAL LANGUAGE PROCESSING AND MACHINE LEARNING
Epidemiological surveillance is key to monitoring and assessing the health of
populations. Drug overdose surveillance has become an increasingly important part of
public health practice as overdose morbidity and mortality has increased due in large part
to the opioid crisis. Monitoring drug overdose mortality relies on death certificate data,
which has several limitations including timeliness and the coding structure used to
identify specific substances that caused death. These limitations stem from the need to
analyze the free-text cause-of-death sections of the death certificate that are completed by
the medical certifier during death investigation. Other fields, including clinical sciences,
have utilized natural language processing (NLP) methods to gain insight from free-text
data, but thus far, adoption of NLP methods in epidemiological surveillance has been
limited. Through a narrative review of NLP methods currently used in public health
surveillance and the integration of two NLP tasks, classification and named entity
recognition, this dissertation enhances the capabilities of public health practitioners and
researchers to perform drug overdose mortality surveillance. This dissertation advances
both surveillance science and public health practice by integrating methods from
bioinformatics into the surveillance pipeline which provides more timely and increased
quality overdose mortality surveillance, which is essential to guiding effective public
health response to the continuing drug overdose epidemic.
KEYWORDS: Machine learning; substance use; drug overdose; surveillance; deep
learning
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CHAPTER 1
Introduction
In 2019, there was a total of 70,630 overdose deaths in the United States,1
increasing from 67,367 overdose deaths 2018.2 Drug overdoses continue to be a major
cause of morbidity and mortality in the United States,2 in large part due to the opioid
epidemic.3-5 Evidence from morbidity data indicates that the novel coronavirus pandemic
has led to increased drug overdoses6 in 2020, suggesting that drug overdose outcomes are
still rising. Identifying and characterizing the burden of the epidemic is critical to
developing interventions and guiding policy and funding initiatives to combat this public
health crisis. Epidemiologists and data scientists working at the state, local, and national
levels use surveillance data to identify regions with high burdens of overdoses,
demographic subgroups at disproportionate risk of overdose, and substances involved7 in
causing morbidity and mortality. Mortality surveillance data has highlighted increases in
deaths caused by drugs such as fentanyl8,9 and psychostimulants.10
Evidence from surveillance data is used to guide public health interventions and
public safety initiatives. To effectively guide practice, surveillance data must be both
accurate and timely. With the ever-changing landscape of the drug overdose epidemic,4
timely data is essential. Public health interventions should be targeted to the specific
substances causing morbidity and mortality in near-real time, not substances that were
affecting the community in a year prior. Similarly, accurately identifying what substances
are causing morbidity and mortality is crucial. Public health interventions for prescription
opioids may consist of increased analysis of prescription drug monitoring program data11
to identify and stop “doctor shopping”, while an initiative aimed at illicit opioid mortality
1

may focus more on supply-side interventions and harm reduction. Similarly, interventions
for preventing opioid overdoses may include expanding access to medication for opioid
use disorder,12,13 while interventions for misuse of methamphetamine, a substance
causing increased morbidity and mortality during the opioid crisis,10 would include
increasing access to cognitive behavioral therapy.14 Without timely and accurate
surveillance data, actionable evidence for the development of public health initiatives will
be limited.
A current barrier in surveillance of drug overdoses is the reliance on death
certificate data for mortality surveillance. While death certificates contain detailed
information about the decedent’s demographics and cause- and manner-of-death, death
certificates often lag behind other surveillance sources due to both the time a death
investigation takes15 and the process of adding International Classification of Diseases,
10th Revision (ICD-10)16 codes to the death certificates. Additionally, medical certifiers
who complete death certificates for drug overdose deaths in some states are not required
to have a medical background.17 The medical certifier is charged with completing the
free-text cause-of-death and description-of-injury sections of the death certificate, from
which information on what substances caused an overdose death is obtained. Data quality
stemming from errors or misspellings in these sections present additional challenges in
using death certificate data. For example, the medical certifier may incorrectly spell the
name of a specific substance, causing the record to be missed when identifying the
number of overdoses involving that substance.
This dissertation aims to address the existing limitations in epidemiological
analyses relying on death certificate data by enhancing the timeliness and completeness
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of the information derived from death certificates to advance drug overdose surveillance
science. The limitations in timeliness and quality both stem from the need to analyze
free-text data, specifically, the free-text cause-of-death section of the death certificate that
is completed by the medical certifier during the death investigation. Free-text data can be
analyzed through the use of natural language processing (NLP) and machine learning
(ML) methods. NLP and ML have seen extensive use in clinical sciences18,19 but only
limited use in public health.20 An example of NLP use in other fields include identifying
drugs from clinical texts,21-23 which could be similarly adopted to identify drugs from
death certificate text.
With the current limitations of death certificate data stemming from the need to
analyze free-text, leveraging NLP methods is the next step in advancing public health
surveillance for drug overdose. NLP provides a suite of methods for transforming
unstructured, free-text data into “features” which can be fed as variables into classical
statistical methods as well as ML algorithms. NLP typically leads to extremely high
dimensional data, necessitating ML models capable of handling high dimensionality to
analyze. In a typical NLP and ML pipeline, data is split into training and testing sections.
Free-text training data is processed via NLP methods and the created features are fed into
an ML model that, using these features, are trained to predict some outcome (y). This
trained algorithm is then deployed onto the test data, predicting the outcome for each
record in the test data set. The model is then scored based on how well it performed on
the test data against a gold standard. The final, trained algorithm can then be used on new
data to predict the outcome when it is unknown or unavailable.

3

The following chapters address three specific aims for developing and integrating
NLP and ML models in the public health surveillance pipeline for drug overdose
mortality to advance surveillance science and improve public health practice through
more timely and accurate surveillance. These aims seek to advance surveillance science
through the tenets of integration (applying techniques that emerged from a different field
allows us to uncover new phenomena, linked to previous work in clinical sciences) and
development (the methods developed in the dissertation are the first of their kind for
applying NLP to overdose mortality surveillance, and provide a base for researchers to
build further NLP models for surveillance), defined as two of the five ways in which
scientific progress is achieved according to the National Research Council.24
•

Aim 1/Chapter 2: Review the existing literature on NLP and ML use in public
health surveillance to identify current uses and gaps in the literature,

•

Aim 2/Chapter 3: Develop a machine learning model that can identify drug
overdose deaths through the analysis of free-text to improve the timeliness of
surveillance data, and

•

Aim 3/Chapter 4: Advance surveillance science by improving the detection and
identification of novel drugs and drug misspellings through a state-of-the-art deep
learning model.

4

CHAPTER 2
Natural language processing and machine learning methods in public health
surveillance: a narrative review

Introduction
Public health surveillance (PHS) is the systematic, ongoing collection of healthrelated data and its use to assess the health of populations.25 PHS is critical for detecting
epidemics,26,27 observing long-term health trends,4,28,29 and detecting emerging threats to
public health.30,31 For example, surveillance of the substance use epidemic has helped
reveal the rise in fentanyl and its contribution to overdoses in the United States.8,9
Traditionally, PHS has relied on structured data sources including death
certificates,5,7,9,28,29,32-35 hospitalization discharge billing data,36,37 disease registries,38,39
and systems that track specific conditions, such as mandatory reporting databases.40 Each
has limitations, including timeliness of death certificate data15,41 and lack of specificity in
the coding structure in hospital billing data.42,43 To address these limitations, PHS has
begun to increasingly rely on unstructured data sources for surveillance such as free-text
chief complaint fields from electronic health record (EHR) and emergency department
data44,45 and narrative text from emergency medical service reports.46-50
Natural language processing (NLP) and machine learning (ML) methods have
been developed and applied in clinical sciences51-53 to analyze free-text data. Broadly,
NLP consists of methods that enable computers to process and analyze human language.
ML algorithms can be used to develop predictive models using variables (“features”)
derived from NLP output. In clinical science, NLP and ML tasks typically focus on
classification (e.g., identifying reportable cancer cases52) or information extraction (e.g.,
5

identification of cardiac risk factors54). Using NLP and ML allows researchers to extract
information without performing lengthy, manual reviews. Relatively recent advances in
ML, particularly deep learning, the use of neural networks with multiple hidden layers for
use on complex, feature-rich data,55 have improved the accuracy of NLP methods.56-59
Compared to relatively common use in clinical science,18,19 NLP and ML have
been used more rarely in PHS. Increased integration of NLP and ML into PHS activities
could advance both the science and practice of surveillance by improving capabilities for
processing bigger, unstructured data.20 Studies examining NLP and ML in PHS have
been published in a variety of sources, given the cross-disciplinary nature of these
methods. This narrative review sought to collect peer-reviewed literature that applied
NLP and ML in PHS and describes the current state of these techniques’ use in the field
and their current and potential future contribution of NLP to the assessment and science
of population health.

Methods
To identify existing literature for this narrative review, PubMed was searched for
articles containing all of the following terms: (“public health” AND “surveillance” AND
“machine learning” AND “natural language processing”). When performed in November
2019, this search resulted in a total of 82 articles. Inclusion criteria consisted of being
peer-reviewed and describing either the development or application of an NLP method
that utilizes ML for PHS purposes. No date cutoff was used to exclude articles.
Of the 82 articles identified, 14 met inclusion criteria. Most of the 68 articles that
did not meet inclusion criteria were articles that developed NLP and ML methods, but not
explicitly for PHS; rather, they mentioned that such a method could be used for PHS in
6

their discussion. Additional reasons for exclusion included articles that applied textmatching methods (such as regular expressions) to analyze text, but did not apply ML
algorithms. The included articles’ reference lists were searched for additional candidates,
resulting in the addition of 8 articles for a total of 22 articles included. An abstraction
form programmed in REDCap was used to guide information abstraction from the
articles. Abstracted information included year published, purpose and rationale, ML task
(the formal purpose of the ML model, in NLP typically classification or information
extraction), training and testing sample size (the number of records used to develop the
ML algorithm and the number of records used to validate the model, respectively),
evaluation metrics, score on final evaluation metric, strengths, limitations, and future
directions noted by the authors.

Results
Of the 22 articles included in this narrative review, 12 involved traditional data
sources41,52,60-69 and 10 involved online media data,70-79 summarized in Tables 1 and 2
respectively. Studies that applied NLP to traditional PHS data covered several health
conditions, including autism spectrum disorder (ASD),61,69,70,77 drug overdose,41
cancer,52,60,62,65,66 and infectious diseases.67 Applying NLP and ML addressed different
challenges in traditional surveillance, including the absence of a defined surveillance
definition,63 lengthy reviews required to identify cases,61,69 and enhancing the timeliness
of reporting.41 Most articles that used online media analyzed Twitter (www.twitter.com)
data; Twitter is a microblogging website where users post “tweets,” messages containing
up to 280 characters. Challenges addressed by utilizing NLP on online media included
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monitoring disease activity in near-real time71,72,75,76,78,79 and monitoring conditions that
are difficult to track typically.70,73,77

Discussion
Applying Natural Language Processing to Traditional Public Health Data Sources
Traditional PHS data that were enhanced with NLP and ML included death
certificate data and emergency department data, including EHRs and pathology reports.
Several studies utilized NLP and ML to address time lags present in mortality
surveillance, which relies on International Classification of Diseases, Tenth Revision
(ICD-10) codes16 for identification of conditions. To eliminate time lag of ICD-10 coding
for drug overdose mortality surveillance, Ward et al developed a support vector machine
(SVM) classifier that utilized features from free-text on an individual’s death certificate
to classify deaths as drug overdose deaths, achieving an F-score80 of 0.97.41 NLP and ML
methods have been similarly used on death certificates for cancer surveillance.62,65,66 Butt
and colleagues66 used previously developed named-entity-recognition tools to extract
features for ML classifiers to identify death certificates as cancer for reporting cancer
cases, resulting in an F-score of 0.99. This methodology was then extended65 to
categorize identified cancers’ ICD-10 codes to determine the type of cancer. While their
analysis achieved high accuracy on common cancers (which made up 85% of all
cancers), results were lower on rare cancers. This limitation was further addressed62 by
developing a hybrid ML and rule-based approach, which achieved an overall F-score of
0.80.
NLP and ML have also been utilized on mortality data for general
surveillance.67,68 Koopman and colleagues67 utilized NLP to extract features for an ML
8

classifier that predicts if a death was caused by diabetes, influenza, pneumonia, or HIV,
achieving an F-score of 0.96, allowing for faster mortality surveillance. Another study
developed a deep learning architecture to perform ICD-10 coding of death certificates
from free-text.68 The final model had an accuracy of 0.76, with infrequently occurring
ICD-10 codes having poor prediction scores. The authors note that sparse modeling
methods could improve the prediction on these rarer ICD-10 codes. While this analysis
had relatively low accuracy, the task of coding every ICD-10 code is ambitious.
PHS utilizing NLP and ML has also been performed for morbidity surveillance
using EHRs63,64 and pathology reports.52,60 Surveillance of suicide attempts is difficult
with structured emergency department data. To address this limitation, Metzger et al64
utilized text from EHRs to develop features for ML classifiers to identify suicide attempt
visits. This method had an F-score of 0.953, and authors intend to integrate the model
into national surveillance. Another analysis of EHR data identified adverse drug events
utilizing named-entity-recognition and relation extraction.63 This analysis compared
classical ML methods to a more state-of-the-art, long-short-term memory (LSTM) model,
with the developed SVM outperforming the LSTM (F-score 0.89), providing evidence
that traditional ML models can still be utilized for PHS over state-of-the-art methods.
Finally, text from pathology reports were used in conjunction with NLP and ML for
reporting to cancer registries. Osborne et al52 developed a ML method to classify
reportable cancer cases among pathology reports, with a maximum entropy model
attaining an F-score of 0.85, while Alawad and colleagues60 developed a multi-task
convolutional neural network to extract case information (histological type, cancer cite,
etc.) required by cancer registries. While the overall scores for this method were not
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particularly strong, the study displayed that multi-task convolutional neural networks
have improved classification performance compared to single-task models, particularly
for imbalanced data.
Another application for morbidity surveillance utilized free-text data from the
Autism and Developmental Disabilities Monitoring network, which are reviewed by
clinicians to identify ASD cases.69 This is a lengthy process that has led to lagging
surveillance. In order to address this time lag, Maenner and colleagues69 developed a
random forest classifier utilizing features from words and phrases from the network’s
data. Their random forest was trained on 1,162 records from 2008 and tested on 1,450
records from 2010. Despite this limited training data, their algorithm resulted in an area
under receiver-operating characteristic curve80 of 0.932. The gold standard method of
estimating prevalence for ASD results in an estimate of 1.55%, while their ML method
estimates a prevalence of 1.46%, showing promise for utilizing the method for ASD
surveillance. Leroy et al61 extended this work by using NLP and ML to extract diagnostic
criteria for ASD from EHRs; while the evaluation scores were not very high (0.76 and
0.43 precision and recall scores, respectively) it is clear there is promise for NLP in ASD
surveillance with additional work needed.

Applying Natural Language Processing to Online Media
While most analyses of online media utilized social media data,70,72-79 Feldman
and colleagues71 used news reports to develop a ML classifier to track global infectious
disease epidemics. Recognizing that media reports often discuss infectious disease
outbreaks prior to the signal in surveillance systems, their developed algorithm takes
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news articles that discuss infectious diseases and identifies those that discuss disease
activity levels. Their ensemble ML model had a final F-score of 0.87, showing potential
for real-time monitoring of disease activity levels with media reports. Limitations of this
include potential error in media reports and data is limited by media interest.
Another study sought to perform PHS on a range of health conditions utilizing
Twitter data.72 A system called “Crowdbreaks”81 was developed that identifies tweets
discussing health conditions, then relying on crowdsourcing for annotation. Several builtin ML models perform surveillance. One task that was explored was performing
sentiment analysis (classifying a tweet as positive, negative, or neutral) on tweets that
discussed vaccines, which resulted in precision and recall scores of 0.77. While
Crowdbreaks is an innovative approach, relying on crowdsourced labels may lead to
errors in labeling (typically, annotating in studies is performed by multiple trained
annotators) and a lack of labeled data to train the built-in models.
Most of the literature that discussed NLP and ML for PHS using social media data
focused on a specific condition, rather than a range of conditions. To address challenges
in substance use surveillance, one analysis identified tweets that discuss prescription
drugs and developed a ML model that identified if the tweet is discussing abuse of the
prescription.77 This study achieved an F-score of only 0.45 in the highest performing
SVM, with a relatively small sample size (6,400 tweets). With a larger sample size, stateof-the-art deep learning models would likely improve classification. Another analysis
focused on substance use sought to use Twitter and Reddit data to identify individuals to
target for substance use disorder interventions.70 Reddit (www.reddit.com) is a
compilation of forums (called “subreddits”) where users can share messages, videos, and
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other content and have discussions. The classifier developed relied primarily on features
from lexicons and lookup tables, and as a short report detailed information about the
modeling strategy is limited. Their final algorithm had an accuracy of 0.90 for identifying
individuals open to recovery interventions.
Two other studies utilized Twitter data for maternal and child health surveillance.
A 2018 analysis identified and characterized tweets discussing birth defects to estimate
the prevalence of specific birth defects, which are difficult to measure.73 A lexicon and
rules were developed and bootstrapping methods were used to classify tweets that
discussed a child with a birth defect and not just discussing birth defects in general. This
approach resulted in a recall score of 0.95, indicating that expert rules can be utilized
effectively for text classification. Sarker et al74 sought to identify women who are
pregnant through user tweets to develop cohort data for drug safety surveillance. Basic
pattern matching filtered tweets to identify if a user is potentially pregnant, and then
several ML models were tested utilizing features derived from tweets to determine which
of the filtered tweets indicated the user is pregnant. Their best performing SVM model
resulted in an F-score of 0.88, outperforming a neural network.
One topic that has been extensively explored was the use of Twitter for influenza
surveillance. A common issue in using Twitter for PHS is filtering tweets that discuss a
disease but are not talking about an individual having the condition. One analysis
explored this issue utilizing a two-staged approach of determining if a tweet 1) discusses
influenza and 2) determining if it is discussing an individual who is infected.78 Their
method was applied at local and national levels, with counts of ML-model identified
tweets highly correlated at the week level with counts of influenza-like-illness (ILI) from
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CDC national surveillance data, but local-level counts not as correlated. Allen et al79
performed a similar analysis, utilizing an SVM to identify tweets that discussed an
influenza infection. Their model’s F-score was 0.786, with significant correlation
between the national ML-model identified rate and the national ILI rate. Similarly to
Broniatowski et al’s study78 however, regional-level surveillance was less accurate.
An additional study76 identified if Twitter users misdiagnose themselves with
influenza to determine if Twitter is a feasible option for influenza surveillance. While
their study was limited by a small sample size (1,274), the analysis indicated that Twitter
data incorrectly reports a flu season occurring from late 2011 to early 2012, despite no
increases in WHO positive influenza counts. A final influenza study75 utilized Twitter
data to extract topics from tweets that mentioned drugs used to treat influenza. Tweets
mentioning influenza drugs of interest were identified and then words from the tweet
were used as features to train ML classifiers that predict if a tweet is indicating
consumption of the mentioned drug. Their highest performing SVM had an F-score of
0.82, indicating promise for tracking drug consumption with Twitter.
A common limitation in studies that use online media is that terminology
individuals use to indicate health conditions are likely different from medical
terminology common in PHS. Tweets often contain abbreviations/slang. Additionally, a
tweet indicating a user has the “flu” may not be discussing influenza at all, as people use
“flu” to indicate a common cold. These limitations should be addressed as social media is
used for disease surveillance. Other limitations include private Twitter accounts, whose
tweets are not available for analysis, and the large samples required for ML models
which first require annotation.
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Public Health Implications
While NLP and ML methods have been used extensively in clinical science to
analyze free-text data,18,19 they have been used less frequently for PHS despite
unstructured data becoming more common.20 NLP and ML methods have shown promise
in studies to enhance surveillance activities, particularly when they focus on a specific
condition opposed to a variety of conditions,41,62,65,66 but their potential has been largely
untapped. Further integrating NLP methods into surveillance workflows will advance
surveillance science and public health practice, with several avenues for advancement
identified through the review. While Ward et al41 classified deaths as drug overdoses, an
extension to this method that identifies the drug(s) that caused the death would further
improve surveillance. Similarly, while detection of cancer-caused deaths had high
scores,66 there is still opportunity to further improve the classification of rare cancers.62
New surveillance systems, such as emergency medical services data,44,45 should be
explored and NLP methods applied to extract information and classify cases.
There are also gaps in the literature on utilizing social media data for PHS. While
influenza has been studied relatively extensively,75,76,78,79 there is little literature on other
infectious diseases. Additionally, given the substance use epidemic occurring in the
United States, there is opportunity to use social media to track trends related to substance
use and misuse. Sentiment analysis on tweets that mention specific drugs could create an
“early warning system” to identify drugs that are rising in use before they appear in
traditional PHS.
Overall, most of the literature reviewed utilized traditional ML models opposed to
deep learning techniques while still achieving high scores. While many of the reviewed
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articles discussed the development of a process to improve surveillance, some studies
lacked key information on how these methods were developed. As public health
researchers begin to use and develop ML models more extensively, care should be taken
to ensure a thorough description of methods is present in articles, including a step-by-step
breakdown of the model’s development. For example, common missing details included
how the model was tuned to select hyperparameter values (cross validation is common
for traditional methods to avoid overfitting82) and clear indication of whether the training
and testing data were split to ensure the model is validated on an out-of-sample dataset,
which could lead to look-ahead bias if it did not occur.83 Table 3 displays facets of ML
algorithm development that should be included in future research. Another limitation that
many studies had was sample size. ML models require relatively large amounts of data
for accurate predictions,84 especially deep learning methods. Finally, most studies
required manual annotation, which can be a costly, time-consuming process. Contributing
more resources to manual annotation on PHS data and social media data will be required
for NLP and ML methods to reach their full potential as a surveillance tool.

Limitations
A limitation of the narrative review format compared to a structured systematic
review is that it does not capture detailed information on the number of articles included
and excluded due to various review criteria, nor does it follow a strict information
extraction protocol. However, the narrative review format was appropriate for the
purpose of providing a general overview of the current state of NLP and ML use in PHS
and identifying future opportunities to use these methods in the field. Another limitation
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of this review was its narrow search criteria; as a result, some studies that fit the overall
purpose of this review may have been missed due to the intentionally narrow inclusion
criteria. Additionally, this review did not examine other text analysis methods (such as
regular expressions and key word searches) that are more frequently used in PHS for
analyzing free-text data. A final limitation is that PubMed was the only database
searched; most if not all articles applying NLP and ML to PHS are likely indexed in
PubMed, but some candidates may have been missed. As NLP and ML become more
widely used in PHS, a systematic review of this topic may become warranted.

Conclusions
While several studies have used NLP and ML methods for PHS, there are
limitations and gaps that these methods can address. With the increasing size of data and
unstructured data existing in public health, utilizing NLP and ML methods is essential for
gaining insights. The overall promise that many studies in this review display indicate
that NLP and ML have an important place in future PHS. These methods have already
improved the timeliness of PHS, extracted additional information from data sources, and
positioned social media as an emerging data source for monitoring disease trends in nearreal time. The continued development and evaluation of these methods will be key to
PHS moving forward.
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Table 1: Articles applying NLP to traditional data sources
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Study
Butt et al
(2013)

Condition(s)
Cancer death

Koopman et
al (2015)

Deaths
caused by
diabetes,
HIV,
pneumonia,
influenza
Cancer death

Koopman et
al (2015)

Osborne et
al (2016)

Cancer cases

Maenner et
al (2016)

Autism
spectrum
disorder

Metzger et
al (2017)

Suicide
attempts

Description of method
Classify cancer deaths
from death certificate
free-text for cancer
registry reporting
Develop a ML model
that predicts if a death is
caused by these
conditions using freetext

ML Task
NLP Task
Binary
Extracting stems,
classification bigrams, and conceptbased features from freetext
Multiclass
Extracting term and
classification concept-based features
from free-text

Key Findings
Traditional ML method was highly
accurate for classifying cancer deaths

Classify the ICD-10
codes of cancer deaths
from free-text death
certificates
Identify cancer cases
that are mandatory
reportable from
pathology reports
Classify case reports to
diagnose autism
spectrum disorder

Multiclass
Extracting term and
classification concept-based features
from free-text

Common cancers had high accuracy,
rare cancers had low accuracy

Binary
Extract concept unique
classification identifiers from
pathology reports

High F-score highlights potential for
automating reporting processes

Binary
Extracting and stemming
classification tokens, creating a termfrequency—inverse
document frequency
matrix
Binary
Extracting concept
classification unique identifiers from
free-text

NLP can be used to classify autism in
reports to estimate prevalence in the
population

Identify suicide
attempts from
emergency department
EHR free-text

These relatively common conditions
can have classification high accuracy
with a single model

Pilot study had high accuracy, authors
seek to deploy as part of a national
surveillance system

Duarte et al
(2018)

All-causes of
death
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Develop a deep learning
model that classifies the
ICD-10 cause of death
from free-text
Munkhdalai Adverse drug Using named-entityet al (2018) events
recognition and relation
extraction, identify
adverse drug events
within EHR free-text
Koopman et Cancer death Develop a hybrid ruleal (2018)
ML model for increased
classification accuracy
of rare cancers
Leroy et al
Autism
Extract diagnostic
(2018)
spectrum
criteria for autism
disorder
spectrum disorder from
EHRs
Ward et al
Drug
Classify deaths caused
(2019)
overdose
by drug overdoses using
death
free-text on death
certificates
Alawad et al Cancer
Extract required case
(2020)
information that cancer
registries require from
pathology reports

Multiclass
Creating word
classification embeddings for the
neural network

Poor prediction scores for infrequently
occurring ICD-10 codes; models for
specific conditions are more accurate

Information
extraction,
relationship
extraction

Traditional model outperformed deep
learning model, indicating that
traditional ML can be used for PHS
successfully

Extract token distance
between entities,
creating word
embeddings

Multiclass
Extracting term and
classification concept-based features
from free-text

Adding rule-based model to ML
increases the accuracy of rare cancer
classification

Information
extraction

Extracting specific criteria for autism is
a more difficult task than classifying
the disease

Extract expressions of
DSM criteria using a
lexicon

Binary
Extract tokens, bigrams,
classification and trigrams from freetext

Traditional ML methods can be utilized
for accurate death certificate
classification of drug overdose

Information
extraction

Low accuracy scores overall, but study
demonstrated promise for multi-task
convolutional neural networks for
imbalanced data

Text pre-processing for
use in several neural
networks

Table 2: Articles applying NLP to online media data sources
Condition(s)

Broniatowski
et al (2013)

Influenza

Sarker et al
(2016)

Prescription
medication
abuse

Mowery
(2016)

Influenza

Allen et al
(2016)

Influenza
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Study

Description of
method
Two-staged
approach to identify
Tweets that mention
influenza and then
identify if the tweet
is discussing an
infected individual
Given a tweet
discussing a
prescription drug,
classify whether or
not the tweet is
discussing abuse of
the drug
Determine if Twitter
is a feasible source
for influenza
surveillance by
analyzing if users
misdiagnose
themselves in tweets
Classify tweets that
discuss an individual
infected with
influenza and utilize
geographic

ML Task

NLP Task

Key Findings

Binary
classification

Extract words,
bigrams, trigrams
from tweets

Trends in classified tweets followed
trends in influenza-like illness
nationally, with less correlation at the
local level

Binary
classification

Stemming,
extracting n-grams,
part-of-speech
tagging

Developed model has a relatively low
F-score, but more state-of-the-art
methods and additional training data
could improve results

Binary
classification

Extract words and
bigrams from tweets

Authors identified a spike in reported
influenza on Twitter during a period
without a real spike, suggesting caution
should be taken when using social
media for surveillance

Binary
classification

Extract words,
bigrams, and
trigrams from tweets

Identified tweet trends were correlated
with national and local data, but with
less correlation at the local level
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Kagashe et al
(2017)

Influenza

Sarker et al
(2017)

Pregnancy

Klein et al
(2018)

Birth defects

Müller et al
(2019)

Various

Feldman et al
(2019)

Infectious
diseases

information systems
to normalize tweets
Develop a classifier
that can track
influenza drug
consumption from
tweets
Using tweets,
classify if a Twitter
user is pregnant for
safety surveillance

Given a tweet
discussing a birth
defect, classify
whether or not the
tweet is discussing a
child with a birth
defect
Using crowdsourced
labeling of tweets,
monitor changes in
disease trends and
beliefs through
social media
Classify news
articles that discuss
infectious diseases
to identify those that

Binary
classification

Binary
classification

Binary
classification

Parsing tweets for
dependency features
to identify words
with relations to an
annotated drug
Extract n-grams and
create word
embeddings for
vector representation
of words, extract
tweet sentiments
Filtering tweets
using lexicon
developed from
Unified Medical
Language System

Several
Create word
including
embeddings for
classification, tweets
sentiment
analysis
Binary
classification

Study showed promise for tracking user
drug consumption through tweets,
which can be used as a proxy for
influenza surveillance
Traditional ML method outperformed
deep learning, providing evidence
traditional ML can still be used for
accurate classification

High evaluation scores indicate
incorporating rule-based methods can
lead to successful classification for
surveillance

An innovative approach, but using
crowdsourced labels as opposed to train
annotators may lead to errors

Extract features from Model has potential for real time
news articles for
identification of outbreaks from media
supervised ML
articles, but is limited by what
conditions the news media is interested
in

Jha, Singh
(2019)

Substance use
disorder

discuss disease
activity
From Reddit posts
and tweets, identify
social media users to
target for substance
use recovery and
interventions

Binary
classification

Sentiment analysis,
drug term
identification

Model developed for Twitter data had
high accuracy, indicating promise for
using social media for this task
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Table 3: Suggested key elements to be reported in publications reporting results of machine learning models applied in public
health surveillance
Topic
Checklist items
 Time period of data collection
 Total sample size
Dataset description
 Training sample size
 Test sample size
 How train/test split was performed
 Detailed description of how features included in
Feature engineering
the model were developed, including published
code if privacy restrictions allow
 Machine learning models used
Algorithms tested
 Describe why these specific models were
selected
 Describe how model hyperparameters were
Training process
selected and any other tuning steps
 List the metrics used for evaluation
Evaluation criteria
 Describe why these are important for the
application

CHAPTER 3
Enhancing timeliness of drug overdose mortality surveillance: a machine learning
approach
Introduction
Death certificates (DCs) are the primary source for state and local drug overdose
(OD) mortality surveillance and are currently the only nationwide source.85 DCs provide
information about decedents (including demographic information, residence, and place of
death), cause and manner of death, and substance(s) involved in an OD that are important
to developing drug OD prevention programs and policies.86,87 In order to design and
implement effective public health interventions, this information must be available to
public health practitioners in a timely manner.
In the case of a suspected drug OD death, a coroner or a medical examiner serving
the jurisdiction where the death occurred determines the cause-of-death and completes a
DC.88,89 The DC is then filed (electronically or as a paper copy) with the state office of
vital statistics (OVS). An electronic record with selected DC fields, including the free
text information for the cause-of-death,90 is transmitted to the National Center for Health
Statistics (NCHS) and coded according to the guidelines of the International
Classification of Diseases, Tenth Revision (ICD-10) to allow standardized classification
of the causes of death.91-94 A copy of the ICD-10-coded record, containing one
underlying cause-of-death (UCOD) and up to 20 supplementary causes of death, is sent
back to the state OVS to be used for epidemiological analysis. There is a significant time
lag between the day of death and the day when an ICD-10-coded DC record is available
for identification of a drug OD death (the consensus definition for drug OD mortality
surveillance is based on the UCOD code in the range X40-X44, X60-X64, X85, or Y1023

Y1495,96). Spencer et al. reported that only 37.8% of the drug OD death certificates are
available to NCHS by 13 weeks (vs. 83.9% for overall deaths), mostly due to delays in
DC completion related to required forensic toxicology analysis.97 Additional time lag is
acquired at the NCHS as about two-thirds of the deaths with an UCOD of drug OD are
coded manually, compared to one-fifth of all-cause deaths.7

Motivation
Understanding the critical role of surveillance data to inform prevention and
response to the opioid epidemic, the Centers for Disease Control and Prevention (CDC)
provided dedicated funding to states to build capacity for more timely and comprehensive
opioid OD surveillance data.98 This paper examines the feasibility of using natural
language processing (NLP) and machine-learning (ML) methods to identify potential OD
deaths from free-text DC fields, allowing the identification of potential drug OD deaths
(and the initiation of gathering of additional medicolegal data for these cases) before the
DC records are sent to the NCHS for ICD-10 coding. Figure 1 displays the overall
workflow of the death investigation and public health surveillance approach; the
proposed method eliminates the time lag associated with steps 3a-7a, replacing these with
steps 3b and 4b. We chose NLP and ML as the methodological base given they (a)
provide an intuitive mapping from free text fields to categories using classification
techniques and (b) are generally more accurate than rule-based systems in data rich
settings. Our main goal is to build a practical computational solution that can be
employed by epidemiologists in public health agencies for near real time OD mortality
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surveillance with reasonably high accuracy. Hence, all the code used in this effort is
made publicly available: https://github.com/pjward5656/dcnlp.

NLP and ML Background
Text is ubiquitous in healthcare and biomedicine coming from different sources
including biomedical literature (journal articles, conference abstracts), clinical notes (e.g.,
discharge summaries and pathology reports), and social media text (e.g., Twitter, Reddit,
and specialized forums such as the Cancer Survivors Network). Text classification
methods from NLP and ML have been shown to play a critical role in health and
biomedical applications especially when structured sources do not fully capture all the
information necessary. The NLP component deals with extracting interesting “features”
(independent variables) based on simple n-grams (typically words and two-to-three word
phrases) and more involved syntactic constructs such as parts-of-speech for each word
(e.g. noun, adjective) and constituency and dependency parse trees that represent interword grammatical relations within each sentence. The ML component then learns a
model with these features as independent variables and the category as the outcome
variable using, typically, hand-coded training data.

A basic text classification problem typically deals with an outcome variable that is
binary. For example, based on a pathology report can we identify whether a cancer case
is reportable or not?52 There could also be cases where the problem is multiclass, where
one of more than two categories ought to be chosen. For instance, in cancer registries,
certified tumor registrars read pathology reports to code major sites from a list of dozens
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of such sites and this task can be expedited using automated methods.51 A variant of the
multiclass problem is ordinal classification, where the categories are ordered in some
manner specific to the task. Although one class is chosen in ordinal models, errors are
counted differently based on how far away the prediction is from the true category. As an
example, in psychiatry a recent shared application53 dealt with assigning symptom
severity categories (absent, mild, moderate, and severe) based on content in a psychiatric
evaluation note. Finally, multilabel classification handles scenarios where more than one
category is typically assigned to each input instance. A use-case is when coders assign
multiple diagnosis codes99 to electronic medical records for every patient visit. For
elaborate details of specific applications of NLP in biomedicine, please refer to broad
reviews.100,101 The problem at hand in this current effort is binary classification to identify
deaths due to OD based on DC text.

Methods
Data
The Kentucky Injury Prevention and Research Center (KIPRC), as bona fide
agent of the Kentucky Department for Public Health, receives weekly extracts of DCs to
perform injury surveillance. Coded DCs for years 2017-2018 as of November 1st, 2018
(n=84,142), were used for this analysis. The ML process requires that the data is split into
training and testing sets; the coded 2017 DCs (n=48,016) were used as training data and
the coded 2018 DCs (n=36,126) were used as testing data. In total, 2,478 (2.9%) of the
DCs were coded as OD deaths based on the ICD-10 code assigned by NCHS in the
UCOD field.102 These cases were treated as the “true positive” cases when training and
testing the ML algorithm.
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Task
The task for the ML algorithm in this paper is to take an un-coded DC and
classify it as an “OD death” or “not OD death” using free-text fields. To automate this
task free-text fields on the DC were used to create features for a classifier. ML algorithms
require feature vectors to train the model. In this analysis, a feature is a binary [0,1]
variable created from an aspect of the free-text present on the DC, and a feature vector is
z-dimensional vector of features where z is the total number of features.

Feature engineering
DCs in Kentucky are certified by county coroners or physicians depending on the
manner of death. The certifier completes the cause-of-death section, consisting of an
“immediate cause” field (“line a”) followed by three sequential fields indicating
conditions that were “leading to the cause listed in line a” 7. In addition, the certifier may
also complete two other sections: 1) “other significant conditions contributing (SCC) to
death but not resulting in the underlying cause” and 2) “describe how the injury
occurred.” The latter is only completed if the death resulted from an injury.
These free-text fields (used by the NCHS to assign ICD-10 codes for underlying
and contributing causes-of-death) were used to create features for the ML algorithm. Two
different field combinations were examined for this task: 1) all three free-text sections of
the death certificate and 2) the cause-of-death section and the description of injury
section. The latter option was considered as ODs and substance use may not cause death
but may contribute to other types of morbidity that later cause death. Excluding the SCC
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section may result in better separation between OD deaths and deaths that involved
substance use or previous ODs.

Certifiers in Kentucky typically do not write in full sentences using grammatically
or syntactically correct language when completing the DC. The text is often concise.
Table 4 shows an example of a typical OD DC. Due to these considerations, to simplify
the task the fields in the training data were combined into one free-text field. All
punctuation was removed from this field. Using the scikit-learn103 library in Python, this
field was tokenized into individual words, bigrams (adjacent two-word sequences), and
trigrams (adjacent three-word sequences), excluding stop words (“the”, “an”, “and”, etc.).
All free-text in the data exists in fully capitalized form, and the capitalized tokens were
used, unaltered, for the analysis. Any token appearing less than five times was discarded.
The 2017 DC data including the SCC field contained 2,184 unique words and 11,261
bi/tri-grams. When excluding the SCC field, the word and bi/tri-gram list decreased to
1,820 and 8,029, respectively. Features for each of these words and phrases were then
created for the model; a feature was given the value of 1 if the word/phrase it represents
appeared in the text and a value of 0 otherwise. To illustrate, a feature representing the
bigram “acute cocaine” would be 1 for the DC in Table 1 while a feature for the word
“poisoning” would be 0.

Classifiers
Several classification methods were considered and examined for this task. Linear
support vector machines (SVM), random forests (RF), and multilayer perceptrons (MLP)
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were tested for this classification task. The SVM approach was selected due to both the
low computational requirements of this method as well as its use in previous, similar
classification tasks,65-67 while RFs and MLPs were examined as more complex nonlinear
methods that may identify additional interaction features compared to the linear SVM.
Figure 2 shows the overall process used to predict if a DC is an OD using only the freetext fields. While this classification task was implemented in the Python environment, the
algorithms tested have well documented and easily programmable methods within the
e1071 and CARET104 packages in R, making this an accessible method.

Training
The algorithms were trained on all coded 2017 DCs using 3 times repeated,
stratified 10-fold cross validation within the scikit-learn Python library. Repeated cross
validation was selected as it is recommended over other methods for general
classification use.82 Stratified cross validation was used so that each fold created during
the procedure would have the same makeup of OD deaths and non-OD deaths that the
entire dataset has (~97% non-OD, ~3% OD) 105. The cost (regularization) hyperparameter
of the linear SVM, the maximum depth, number of trees, and maximum number of
features hyperparameters of the RF, and the hidden layer sizes and alpha (regularization)
hyperparameters of the MLP were tuned based on F-score, the harmonic mean of positive
predictive value (PPV) and sensitivity.80 F-score was selected as the tuning metric due to
the class imbalance in the data; tuning based on accuracy would bias the algorithm to
correctly classifying non-OD cases, as ~97% of the data are not OD deaths. To tune the
hyperparameters, potential values were initially selected.. After training on these values,
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an additional search was performed around the value(s) that the previous step indicated
was the best value(s) for the hyperparameter(s). This process was repeated subsequent
times until the ideal hyperparameter value(s) was identified. After this, the entire training
data was re-trained using the ideal value(s). This tuning approach was implemented as it
is a straightforward grid-search method commonly used for tuning ML algorithms.106

Testing
After the learner was trained on the 2017 DC data it was deployed on the 2018
DC data. The same word/phrase features used in the 2017 DC data were created for the
2018 DC data. Both free-text field combination algorithms were tested.

Rule-based method
A final rule-based classification method was also tested for this analysis on the
2018 DC data. This rule-based method scanned the free text of the DCs for 37 words or
bigrams that were indicative of an OD death. These words/bigrams were selected from a
review of OD DCs by epidemiologists with a combined 10 years of experience in OD
surveillance. For this review, 2017 OD deaths were examined and common tokens
identified. These words and bigrams are available in Appendix 1. Any DC that contained
one or more of the words/bigrams in this list were automatically classified as an OD
death, and any death that did not contain a word/bigram in this list were classified as a
non-OD death. This rule-based method is a simpler version of previously proposed textmatching methods,107 and acts as a baseline to compare to the more computationally
costly ML models.
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Evaluation
Methods were evaluated based on their performance on the test data. To compare
the results of the methods the F-score was calculated along with sensitivity and PPV. For
this task PPV was considered the most important metric, as large numbers of false
positives could be problematic when attempting to develop near real-time interventions
for an OD outbreak. Two-proportion z-tests were performed to test for statistically
significant differences between the sensitivity and PPV of the best performing ML model
and rule-based method.

Results
The model including all three sections had a total of 13,445 features while the
model excluding the SCC section had a total of 9,849 features. Computing time for
training the ML models was not significant; even when using stratified 10-fold, 3 times
repeated cross validation the longest any model took to train was roughly ~3 hours on a
Windows machine with 32 GB of RAM. Deploying the models on the 2018 data took
seconds. The rule-based method does not involve any training and produced predictions
instantly.
Table 5 displays the F-score, sensitivity, and PPV from the final methods when
training the models with features constructed from all three sections and Table 6 displays
the results when training the models with features from the cause-of-death and
description of injury sections. All of the models were highly specific. Only ~3% of all
deaths in the data were OD deaths and all of the ML models had high performance in
identifying deaths that were not OD deaths. The ML models without the SCC section,
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however, all performed equally or higher than their counterpart ML models with the SCC
section with regards to sensitivity, PPV, and F-score. The SVM model without the SCC
section was the best performing model overall, with an F-score of 0.9695, and also
achieved the highest PPV (0.9622), while the RF model without the SCC section
achieved the highest sensitivity (0.9803). Table 7 displays the confusion matrix for the
SVM excluding the SCC section while Table 8 displays the confusion matrix for the rulebased model excluding the SCC section.
The rule-based models did not perform as well as their counterpart ML models.
The rule-based model excluding the SCC section had similar PPV to the ML models
(0.9504), however this model had lower sensitivity than the ML models (0.9243). The
rule-based model excluding the SCC section had a higher F-score than the rule based
model including this section, similar to the results of the ML models. Comparing the best
performing ML model (SVM, Table 6) to the best performing rule-based model (Rulebased, Table 6), two-proportion single-tailed z-tests show that the ML model has a
significantly higher sensitivity (p<0.001) but no statistical difference for PPV (p=0.13).

Discussion
Model performance
This paper presents an accessible method to quickly identify OD deaths from freetext DCs for rapid surveillance purposes. The performance of the ML algorithms
developed were very high. The F-score of 0.9695 for the best performing model is
comparable, and in some cases superior, to that of other models for cause-of-death
classification in the literature,65-68,108 many of which were trained on larger datasets with
more common causes of death. The ML models performed higher than their counterpart
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rule-based models, including significantly higher results for sensitivity, providing
evidence for further increasing the use of ML in public health surveillance over more
traditional methods.
Of the methods compared, the ML models that excluded the SCC section
produced the best performing models, as the ML models that included all three sections
had more false positives than their counterpart models. This is likely because features that
identify an OD death when appearing in the description of injury section or the cause-ofdeath section have different meaning in the SCC section. For example, the bigram “drug
overdose” clearly indicates the death was caused by an OD when present in the cause-ofdeath section, but when present in the SCC section may indicate that the individual had a
previous OD event, but it did not directly lead to death. Including the SCC section results
in a feature space that contains information that is not directly involved in causing death,
leading to a slightly biased model. Further research should examine including the SCC
section in a classifier to identify drug-related deaths, which are important for drug-related
surveillance.

Public health implications
DC data is the only national source for OD mortality surveillance85 and as such is
extremely important for understanding the opioid epidemic and developing responses to
it. These data, however, comes at a non-trivial time lag7,97 that prohibit availability of
actionable data until several weeks following the event of an OD death. The method
proposed in the present study eliminates the time lag from transferring DCs between the
state OVS and the NCHS and the time for ICD-10 coding by the NCHS, thus allowing
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state or local jurisdictions to process their own mortality data as soon as the DC is
available in their database with free-text cause-of-death information. This provides more
timely provisional counts for OD deaths, allowing for detection of overdose death spikes
and identification of new patterns in contributing drugs in a shorter time window, which
could be key as novel designer drugs emerge.3,8,109 This could lead to faster mobilization
of community stakeholders to implement harm reduction strategies, such as targeted
naloxone distribution to communities.
An additional application of the ML method developed is its potential use as a
data quality instrument. While many OD deaths are manually coded at NCHS,7 there is
still the potential for coding errors to occur. Records that the classifier identifies as OD
deaths but NCHS codes as non-OD deaths (false positives) can be reviewed by a medical
examiner to determine if the case is truly a false positive or if the UCOD was coded
incorrectly. This data quality process will capture OD deaths that previously were not
identified and lead to more accurate, complete surveillance of the OD epidemic.

Future directions
To further improve this model, additional feature engineering could be explored.
This could include adding regular expression features to the model to identify patterns
that frequently appear on OD DCs. Additionally, more n-gram features (such as nonadjacent bigrams) could be added to the model. Features that do not arise from NLP that
use other fields on the DC (demographics, manner of death, place of death, etc.) could
also be exploited in a future classifier. Part-of-speech tagging and dependency parsing,
which creates a tree-like structure that explains the grammatical relationships between
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words in sentences,110 was considered for generating additional features for this analysis.
Likely because the free-text present on DCs is often not grammatically correct, these
features did not significantly increase the predictive power of the models. To build a
simpler model they were excluded from the final analysis.
Deep neural networks, specifically convolutional neural networks, were
considered for use in this task as they have been used for classifying free-text DCs.68,108
Due to the small amount of text present on DCs (some contain only two words) a
traditional classification method was selected in our effort. Future research should
examine deep learning methods (particularly the use of pre-trained word embeddings)
and determine if they have higher performance for this task. In general, however,
improving performance scores that are already in the high nineties (our F-score was
0.9695) will be a challenging endeavor that is worth further exploration. Deep learning
should also be explored in the future for more complicated DC classification tasks,
particularly multilabel classification of the substances that caused a drug OD death. An
OD DC may contain no information about the substances causing the drug OD or list
several substances involved in the death. A deep learning framework that can classify
drug OD deaths and the substances causing the death from DC free-text would be a
noteworthy extension to the methods developed in the present study. Since the
completion of postmortem toxicology alone can delay the completion of the DC for
weeks, the next step for improved timeliness in OD death surveillance is to expand the
proposed machine learning models to work directly on medicolegal death investigation
data, utilizing unstructured data from coroner and medical examiner case management
systems (e.g., death scene investigation notes, autopsy reports, police reports, coroner
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notes) thus identifying likely drug overdose cases before the DC is officially filed. As
these reports typically contain much more free-text than DCs, deep learning models
should be explored for this process as well.

Strengths and limitations
The present study has several strengths. A thorough literature review indicates
that this is the first study of its kind to our knowledge to describe a method for classifying
OD deaths from free-text DCs using NLP and ML. The design of this experiment mimics
how the model would be applied in a real-life use case scenario, with features engineered
from previous year(s) data exploited to classify new data, giving the metrics on the test
data validity for future use. This setup also adds to the difficulty of the task, as new
substances that may be important in drug OD classification in a future year may not be
present in the past year that the algorithm was trained on. Despite this, the ML models
excluding the SCC field all achieved F-scores above 0.96.
Another strength of this study is the availability of data for our models to be
tested on, further research to be performed, and similar algorithms to be developed. A
major limitation of most ML applications is the large amounts of training data needed
which coincides with the long, tedious process of labeling training data. Previous years
coded DCs, however, are readily available for training at most state’s health departments.
These DCs are ready to be used for training ML models without the typical initial
requirement of labeling. This labeled data, while not publically available, can be
requested from states’ OVS for research purposes. In addition, the NCHS operates the
Research Data Center (RDC) to allow researchers access to restricted-use data. In 2019,

36

the NCHS made available to researchers a Redacted Death Certificate Literal Text File
(LTF)111 that includes the cause-of-death text record for every U.S. resident death. The
access to LTF will allow researchers to test our GitHub source code on DC records that
come from all U.S. jurisdictions.
The study has some limitations. First, the models were trained on only Kentucky
DCs, meaning that the model may not perform as well on data from other jurisdictions if
certifiers use different words or phrases on their DCs. Kentucky, however, has a hybridcoroner/medical examiner system with 120 county coroners and deputy coroners who
certify deaths (per KRS 72.025) along with medical examiners who assist coroners in
determining the cause and manner of deaths.112 Physicians also certify natural deaths.
Therefore, there is a diverse group of individuals certifying deaths in Kentucky, meaning
the language on Kentucky DCs represents a range of medical backgrounds. Another
limitation, inherent in ML, is the difficulty in diagnosing errors. The models described
here have features numbering near the 10,000s—determining exactly what features are
causing the model to incorrectly predict is inherently more difficult than for a simpler
model with a small number of variables. A detailed error analysis of the SVM model
excluding the SCC field is available in Appendix 2.

Conclusion
The present study compares three methods for identifying OD deaths from freetext DCs using NLP and several ML models as well as a simple rule-based method.
Classifying OD deaths using free-text would substantially reduce the time it currently
takes a surveillance systems to identify OD deaths, from several months to a few weeks.
The described ML methods performed better than the rule-based methods on testing data,
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providing evidence that ML methods should be implemented in public health surveillance
tasks, particularly for OD mortality surveillance. The programming code used to develop
the model is publically available, which can facilitate further testing and development in
other jurisdictions. Further research is needed to explore the potential for other causes of
death to be classified using ML methods as well as additional exploration of ML,
including deep learning, to improve drug-related surveillance
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Figure 1: Certification, registration, and analysis of drug overdose deaths
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Figure 2: Example Analytic Pipeline
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Table 4: Example Death Certificate Free Text
Field
Immediate cause-of-death
Due to (or as a consequence of)
Due to (or as a consequence of)
Due to (or as a consequence of)
Significant conditions
contributing
Description of injury

Text
ACUTE COCAINE TOXICITY

HYPERTENSIVE CARDIOVASCULAR
DISEASE, OBESITY
ACCIDENTAL OVERDOSE
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Table 5: Final model results on test data, features from all death certificate sections
Method
SVM
RF
MLP
Rule-based

PPV
0.9549
0.9328
0.9518
0.9215

42

Sensitivity
0.9748
0.9748
0.9737
0.9265

F-score
0.9647
0.9533
0.9626
0.9240

Table 6: Final model results on test data, features from cause-of-death and
description of injury fields
Method
SVM
RF
MLP
Rule-based

PPV
0.9622
0.9531
0.9621
0.9504
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Sensitivity
0.9770
0.9803
0.9737
0.9243

F-score
0.9695
0.9665
0.9678
0.9372

Table 7: Confusion matrix, SVM model, features from cause-of-death and
description of injury fields

Predicted
Label

Drug OD
Not Drug OD
Totals

UCOD Label
Drug OD
Not Drug OD
891
35
21
35,179
912
35,214
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Totals
926
35,200
36,126

Table 8: Confusion matrix, rule-base model, features from cause-of-death and
description of injury fields

Predicted
Label

Drug OD
Not Drug OD
Totals

UCOD Label
Drug OD
Not Drug OD
843
44
69
35,170
912
35,214
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Totals
887
35,239
36,126

CHAPTER 4
Deep neural networks for fine-grained surveillance of overdose mortality

Introduction
Death certificates (DCs) are the primary data source for drug overdose (OD)
mortality surveillance, providing information about the cause- and manner-of-death.2,5
Medical certifiers write the cause-of-death in free-text fields on the DC,7,113 which are
then used to assign International Classification of Diseases, 10th Revision16 (ICD-10)
codes by the National Center for Health Statistics (NCHS) to each death certificate. ICD10 codes are used at the national and local levels to calculate OD mortality statistics, to
monitor trends in the drugs involved in overdoses, and for epidemiological analyses.
Specifically, ICD-10 codes assigned as an underlying cause-of-death are used to identify
drug OD deaths and those assigned as supplemental cause-of-death codes (up to 20) are
used to identify the drug(s) involved in the OD.2,7,102 This process is central to the
surveillance of drug OD mortality and is the primary way in which OD mortality
information is reported to communities.
The ICD-10 classification process of drug overdose deaths (also called drug
poisoning in the ICD-10 terminology) has limitations, however, including timeliness of
data,7,15 and the lack of fine-grained granularity in the coding structure of ICD-10 for
identification of specific drugs contributing to an overdose death.114 Some drugs have
specific codes (e.g., T40.1 indicates heroin involvement, T40.3 indicates methadone
involvement), but other drugs of interest do not. For example, ICD-10 code T43.6
specifies poisoning by “psychostimulants with abuse potential10”, which includes illicit
substances such as methamphetamine and MDMA in addition to licit substances such as
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prescription amphetamine but excludes the psychostimulant cocaine, which has its own
ICD-10 code (T40.5).10 ICD-10 code T40.4 specifies “synthetic narcotics5”, which
includes fentanyl (prescribed or illicitly manufactured) and fentanyl analogs that have
been a major cause of drug OD deaths in the United States,4,8,9 but also prescription drugs
like tramadol.
This inexhaustive coding structure of ICD-10 has led epidemiologists at the
national and local levels to rely on text analyses to identify specific drugs involved in OD
deaths when the codes present are not indicative of a specific drug. In 2015, the Council
of State and Territorial Epidemiologists (CSTE) released a tool to identify specific drug
mentions from the free-text cause-of-death section of DCs.115 This tool consisted of a
SAS program115 that looped through individual words in the cause-of-death section and
matched the words to a lookup table containing search terms (dug names, metabolites,
and common misspellings) and a crosswalk to a referent drug. The tool produced a list of
drugs found in each record. In 2016, the NCHS developed a methodology for identifying
specific drug involvement from the cause-of-death section that again relied on a lookuptable.7 This methodology additionally considered contextual information and had a more
extensive table than the CSTE tool. While these tools presented improvements over using
ICD-10 codes alone, they were limited by their respective lookup tables, requiring
frequent updates with novel drugs. Additionally, maintaining every possible misspelling
or metabolite for substances is a difficult, ongoing, and resource-intensive task.
Modern approaches within the field of natural language processing (NLP),
including named entity recognition (NER),116 could be applied in the area of drug
overdose surveillance to 1) expedite the process for identifying potential drug overdose
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deaths before the ICD-10 coding of the death certificates is completed; and 2) improve
the identification of specific drug involvement by identifying drug search terms that are
missing in the lookup tables.
NER involves tagging particular words as “named entities” (e.g., relevant to
overdoses, tagging substance names, misspellings, metabolites, and generics as “drug
entities”) and then training a machine learning (ML) algorithm to identify these entities
from free-text. This allows for the trained algorithm to predict what word(s) on new DC
records are drug entities.22,23,117
Modern NER techniques leverage deep learning21,117-119 methods that involve
artificial neural networks with several hidden layers. This allows for the model to
automatically learn complex and robust features that are predictive of outcomes based on
textual inputs.120 Manual feature engineering that was the hallmark of traditional NLP
methods gave way to dense neural representations that have been shown to be more
powerful in information extraction applications, including our current task. An advantage
of this approach is that NER does not rely on a lookup table to determine which word(s)
are indicative of a substance, rather, the ML algorithm through training learns which
words (and surrounding contexts) are indicative of substances. NER has been extensively
used in clinical science to identify substances in free-text,21-23,117,121 but has not been
utilized for DCs to our knowledge.
The present study sought to advance the science and practice of drug OD
mortality surveillance through the development of a modern NER tool for identifying
substances on drug OD DCs. Integrating NER methods into the drug OD mortality
surveillance pipeline will advance surveillance science,24 and in turn enhance public
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health practice by improving the granularity and timeliness of OD mortality surveillance.
This study demonstrates how the adaptation of the NER methodology enhances the
current public health surveillance practice of identification of specific drug involvement
in ODs.

Methods
Data
Data for this study was extracted from the Kentucky Death Certificate Database,
Kentucky Office of Vital Statistics, Department of Public Health on March 9th, 2020. All
records coded with the consensus definition for drug OD death2 for years 2014-2019
were identified and pulled from the database, resulting in a total of n=8,146 OD DC
records used to develop the NER drug identification tool. Using R,122 the free-text data
was parsed and reshaped so that every row was one individual element of the free-text
from the cause-of-death section. To demonstrate, a DC that said “HEROIN,
FENTANYL, AND OXYCODONE OVERDOSE” was transformed into 7 rows (one for
each token), corresponding to the elements “HEROIN”, “,”, “FENTANYL”, “,”, “AND”,
“OXYCODONE”, “OVERDOSE”. This process resulted in a dataset with 95,566 total
tokens. The text on the death certificates is fully capitalized, and these tokens were used,
unaltered.

Annotation
To tag the individual words as drug entities, the dataset was split in half. Two
trained annotators labeled each split according to the beginning, inside, last, outside, unit
(BILOU) tagging scheme.123 In the BILOU scheme, a single word that represents an
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entity is tagged as “U-entity” (unit). An entity that spans numerous tokens is tagged with
“B-entity” (beginning), “I-entity” (inside), and “L-entity” (last), for the first token in the
entity, any tokens between the first and last tokens in the entity, and the last token in the
entity, respectively. Any words that do not represent an entity of interest are tagged with
“O” (outside). Table 9 shows how a record annotated with the BILOU scheme looks for
drug entities. Kappa statistics were calculated for each split and for the entire dataset.
Any disagreements between annotators were identified and resolved at meetings of all
four annotators to produce the final, annotated dataset.

NER Drug Identification Tool and Modeling strategy
Development of the NER tool utilized the Flair124 library in Python. Flair is a
flexible, powerful NLP library that provides a suite of word embeddings125 in addition to
an easy to navigate modeling framework for programming deep neural networks for NLP
tasks, including NER. Word embeddings are semantic vector-space representations of
words. In a typical embedding setting, words that are closely related have similar vector
representations, which provides a more desirable quality for word-representation in NLP
tasks compared to simple dictionary-key representations. The Flair library provides both
previously developed embeddings (such as GloVe125) as well as Flair embeddings,124
which were developed using a character-level recurrent neural model that is
contextualized by surrounding text, meaning an individual word can have multiple
embeddings depending on the context. More recently, Flair embeddings were extended to
“pooled Flair embeddings,126” which addresses the limitation of producing useful
embeddings for rarely used words.
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In general, development of a model in the Flair framework follows the following
steps: 1) labeled corpus creation, consisting of creating a train-test-validation split and
pre-processing data to fit into Flair’s framework; 2) choosing word embeddings; 3)
selecting a model; 4) training the chosen model using the selected embeddings. For the
present study, two models were developed using this framework, only differing in step 2.
The n=8,146 DCs were split into training (n=6,108), validation (n=816), and test
(n=1,222 DCs) sets, roughly a 75%-10%-15% split, respectively. This split was
performed chronologically; DC records were sorted by date of death, and the first 75%
were assigned to the training data, the next 10% were assigned to the validation data, and
the final 15% were assigned to the test data. For word embeddings, a model with GloVe
embeddings was developed as well as a model using forwards- and backwards-trained
pooled Flair embeddings. Hypothetically, the contextual Flair embeddings should outperform GloVe. Testing the pooled embeddings was of interest as DC text contains
frequent misspellings as well as rare words such as metabolites of drugs and novel
substances. The model development pipeline is displayed in Figure 3.
The modeling framework selected was a bidirectional long-short-term memory
(BiLSTM) conditional random field (CRF) model. BiLSTM-CRF was selected as it
achieved state-of-the-art performance in NER tasks previously.119 Flair has a BiLSTMCRF model built into the library, which utilizes the PyTorch framework.127 For training,
the model was set to run for 150 epochs. After each epoch, the model was tested on the
validation set and the model’s accuracy was calculated. The highest-scoring model on the
validation set was saved during training and deployed on the test data. Documented code
for this process is available in Appendix 3. Positive predictive value (PPV), sensitivity,
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and F-score (harmonic mean of PPV and sensitivity)80 were calculated for each models’
performance on the test set for evaluation. High PPV indicates that there are few false
positives; a PPV of 90% means that 9 out of every 10 entities the model identifies as drug
entities are truly drug entities. In this example, the false positive rate is 10%. High
sensitivity indicates that there are few false negatives; a sensitivity of 90% means that 9
out of every 10 tokens that are truly drug entities are correctly identified as drug entities.
In this example, the false negative rate is 10%. F-score provides one score to directly
compare competing models. To demonstrate the advantage of the deep learning approach
over traditional machine learning methods, a Naïve Bayes model was also developed
using a dictionary-key representation for words and evaluated on the test data for a
baseline comparison.

Comparison to lookup table approach
A widely used methodology for identification of specific drug involvement is
based on literal text search for drug names, metabolites, and misspellings, cross-walked
to a “referent drug” and included in a lookup table of search terms. The methodology was
described and implemented in a CSTE tool115 in 2015. The Kentucky Drug Overdose
Fatality Surveillance System32 has been updating the initial CSTE dictionary, and the
current table includes more than 250 referent drugs (Appendix 4). To determine if the
NER model provides an improvement over current methods, the lookup table approach
was used to identify drug entities on the test data. Unlike the neural NER model
developed, the lookup table approach has no false positives (as any word identified from
the lookup table is already confirmed to be a drug). The number of entities that the best
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performing BiLSTM-CRF identified that the lookup table did not was calculated to
display how adding entities identified from the NER model could improve existing
dictionaries.

Results
Annotation
The dataset had a total of n=95,566 tokens that required annotation and each
token needed to be assigned a BILOU tag as discussed in the Methods. The kappa
statistic between the first two annotators (first half of the dataset) was 0.996 and between
the second two annotators (second half of the dataset) 0.973. Overall, the entire dataset
after annotation had a kappa statistic of 0.983. The kappa values indicate the annotation
task resulted in “perfect” inter-rater agreement level as per suggested rule of thumb129
making it a very high-quality dataset.

Modeling
Table 10 displays the results from the respective BiLSTM-CRF models with the
basic GloVe embeddings and Flair embeddings as well as the results from the Naïve
Bayes model. While both deep learning models achieved considerably high performance
for this task, the model utilizing pooled Flair embeddings performed better, with both
fewer false positives and false negatives, resulting in higher scores for Flair vs GloVe for
PPV (99.16% vs 98.63% ), sensitivity (99.10% vs 98.08%) and F-score (99.13% vs
98.35%). Both deep learning models achieved substantially higher scores than the
baseline Naïve Bayes model (F-score=15.58%). Figure 4 displays the validation loss
during training for the pooled Flair model.
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The BiLSTM-CRF model using pooled Flair embeddings was able to recognize
drug entities that the lookup table was not. In total, the deep learning approach identified
168 more entities than the lookup table did. Appendix 5 displays the 130 unique drug
search terms that the lookup table did not contain that were present in the test data. Many
of these entities were terms that spanned multiple tokens, such as “DESIGNER
OPIOIDS”. While the lookup table had the term “OPIOIDS”, the deep learning method
identified the entity “DESIGNER OPIOIDS”, which provides more information on the
specific drug than the term “OPIOIDS” alone. Other missed entities included
misspellings, such as “OXMORPHONE”, “ALPRAZOLM”, and
“METHAMPHETTAMINE”, which all have the correctly spelled terms in the lookup
table but not these specific misspellings. Table 11 displays 3 example death certificate
records and shows the entities identified by each approach. By contrast, there 13
instances where the opposite occurred, in which the lookup table identified a drug entity
when the NER model did not.

Discussion
Model Performance
This study presents a highly accurate method for identifying drug entities on freetext drug OD DCs utilizing a modern NLP model. The F-score of 99.13% for identifying
drug entities achieved in the present study show significant promise for using deep
learning methods in public health surveillance. The BiLSTM-CRF model leveraging
pooled Flair embeddings also identified substantially more drug entities than the current
lookup table for identifying drugs on free-text DCs, clearly displaying that this method is
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an improvement over currently available surveillance tools. In total, the best deep
learning approach identified 130 new unique drug entities compared to the lookup table.
During training, the model achieved lower (better) loss on the validation data than
the training data, as displayed in Figure 4. This is an unexpected result, as typically
models will have higher scores on the in-sample training data than the out-of-sample
validation set. Potential reasons for this include the relatively small sample size of the
validation set (n=816) compared to the training set (n=6,108). Additionally, it is possible
that the training data contained more difficult examples for the model to categorize than
the validation data. A practical reason for this is how the data was split; the training data
includes the oldest (chronologically) DC records. In Kentucky, public health initiatives
have worked with medical certifiers to improve DC completion and accuracy for drug
overdose deaths, so DCs completed earlier in the epidemic may be of lower quality and
thus more difficult for the model to learn than more recent DCs.

Implications for public health practice
While knowledge of deep learning methods and NER is not typically part of a
public health practitioner’s toolkit, epidemiologists working in OD surveillance possess
knowledge of programming and text analytic tools as they have become required for
identifying drugs that cause morbidity and mortality in communities.7 The high
performance achieved by the developed model shows that deep learning should be
leveraged moving forward in public health practice as a tool to solve challenges that
appear in free-text data. Epidemiologists working at the state, local, and national levels
should develop and implement these methods into surveillance pipelines to both improve
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public health practice and improve surveillance data quality. Neural NLP methods will
become essential as public health surveillance continues using more data sources that
contain free-text, including electronic health records,40,49,61,64 emergency medical services
run data,44,45,130,131 and syndromic surveillance,27,46,48,132 which are used for both drug
ODs and other health conditions.
As many jurisdictions performing OD mortality surveillance will not have the
expertise nor the computational power to develop and test NLP models, the developed
model can advance surveillance efforts through improvement of the current surveillance
pipeline. In analysis of Kentucky data alone, the deep learning model identified over 100
unique drug entities that a lookup table did not contain. Identified entities can be
extracted from the model’s results and added to the lookup tables of current tools, which
can be disseminated to jurisdictions to improve identification of specific drugs. This will
allow for the increased specificity of drug entities that the model provides without
needing to run a complex model in situations where computational power or expertise is
limited. With periodic runs on a fresh set of DCs, our model can thus surface new drug
terms and improve operations in jurisdictions that do not necessarily have the resources
to train and deploy neural models.
Integration of additional entities recognized by the model into existing tools in the
drug OD mortality surveillance workflow will increase the specificity of drugs identified
on OD DCs through fine-grained spotting, compared to both ICD-10 coding and other
methods.7 Importantly, ongoing application of the NLP approach as part of the routine
drug OD surveillance analysis will allow for the detection of novel substances as soon as
they appear on a death certificate, before the lookup tables are updated with the new
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substance names. Addition of a new substance to a lookup table depends on
circumstances within a rapidly changing drug market, which can be demanding, as
evidenced by the difference in performance between the two lookup table methods tested.
Since the developed algorithm can utilize context, it has the ability to recognize novel
drug entities without constant modification of the underlying model. The model’s ability
to recognize novel entities will provide the opportunity for early warning signals for
novel substances, and thus faster public health and public safety response. Additionally,
the increased granularity will provide an overall improvement in surveillance data
quality, which will lead to more accurate reporting of information to communities and
stakeholders. The proposed neural NER methods expand our previous work on DC freetext41 where we developed a NLP algorithm to capture drug OD death cases prior to ICD10 coding. In combination, the two NLP algorithms can be added to the routine drug OD
mortality surveillance tools to improve the early identification of drug OD deaths and
emerging new drugs of concern, providing opportunities for timelier public health and
safety response.

Future research
Future studies should apply the developed model to data from other jurisdictions
and assess the model’s performance to explore generalizability of the model. This
generalizability would indicate that the model can be directly integrated into the
surveillance work of other states and localities without the need for annotation and
training. Additionally, future research should utilize a similar workflow for identifying
substances on other surveillance data sources. While it is unlikely that the developed
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model, due to the nature of DC free-text, would achieve high scores on other free-text
OD surveillance sources such as emergency medical services run data, future studies
should explore the use of the Flair library and particularly pooled Flair embeddings for
drug NER tasks. One limitation of the lookup table approach for identification of drugs
involved in fatal ODs is the lack of context analysis. For example, if “history of heroin
abuse” was mentioned on a drug OD death certificate, the lookup table approach as well
as our currently proposed NLP algorithm would identify the OD death as heroininvolved. Since NLP methods can be trained to recognize context, a future improvement
of our NLP algorithm would be the filtering out of the drug entities in situations where
the drugs were not mentioned as contributory to the OD death. This specific scenario did
not occur frequently in Kentucky data used to develop the model, but will be an
important improvement to avoid false positive cases for drug OD involvement of specific
drugs.

Strengths and limitations
The developed method has several strengths. First, the developed dataset
consisted of a large sample (n=8,146) of OD DCs spanning multiple years of data. The
dataset was annotated by 4 trained annotators, ensuring accurate labels were produced
which was verified by a high overall kappa statistic (0.983). Another strength of the
method was the way in which the train-validation-test split was performed. By using
earlier records for training and validation, and testing on later DCs, the model
demonstrated that it can use older data to produce accurate predictions on new data,
mimicking the real-world use-case of the model. The final strength of the model is the
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high F-score (99.13%) achieved, displaying high accuracy for identifying drug entities on
free-text DCs.
The study does have a few limitations. A primary limitation is that the developed
NER model cannot be used as a stand-alone surveillance tool; rather, it should be
implemented as an enhancement in current OD mortality surveillance work to improve
drug identification on death certificates. The lookup table-based methods contain
crosswalks of drug search terms to their parent drug (for example, misspelling
“CLONAZPAM” is cross-walked to parent drug “CLONAZEPAM”). Since the NER
method, by design, recognizes novel entities, these entities are not present in dictionaries
and their respective crosswalks, and therefore the NER model cannot be used as a
surveillance tool alone. This limitation is addressed, however, by utilizing the model
periodically on new data to recognize novel entities and adding these entities to existing
lookup tables, so that novel entities can be identified by surveillance tools. Further, the
inclusion of an entity in a lookup table guarantees that it will be recognized on every
record it appears in, regardless of context—this addresses the rarely occurring scenario
when a drug entity was not identified by the NER model due to it appearing in different
context than the model learned.
An additional limitation is that the entirety of the data used for training the model
came from Kentucky DCs. The performance of the model on data from other jurisdictions
should be evaluated. Additionally, the comparison of model performance to performance
of the lookup table method is conditional on how up-to-date a given lookup table is; other
jurisdictions may have more complete tables, so the performance improvement from the
NER model may not be as high as in the present analysis. Another limitation is the
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complexity of the method and the need for computationally powerful hardware when
applied to large datasets. Finally, the complexity of the model makes diagnosing errors
difficult, which is an inherent limitation in most ML applications.

Conclusion
To our knowledge, this study is the first of its kind to use deep neural networks
for drug NER on DCs. The highest performing model developed achieved an F-score of
99.13%, indicating that the method is highly accurate at this task. The high performance
of the developed model clearly shows that deep learning models should be integrated into
public health surveillance workflows. Particularly for drug OD mortality surveillance, the
method could improve surveillance data quality and timeliness, enabling public health
practitioners to more quickly recognize novel substances and more accurately report data
to communities. The developed method advances the science of public health
surveillance by integrating NLP models not currently used in the field into surveillance
workflows and advance public health practice through enhancing both data quality and
timeliness of reporting. These surveillance improvements are key in monitoring the
continuing drug OD epidemic and informing interventions to address this national crisis.
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Table 9: Example Annotated Death Certificate Free-text
Word
7
AMINOCLONAZEPAM
AND
HEROIN
OVERDOSE

Tag
B-drug
I-drug
L-drug
O
U-drug
O
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Figure 3: Flair NLP model development and evaluation for overdose mortality
surveillance
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Table 10: Performance of machine learning models on test set
Method
Tested
GloVe
Pooled Flair
Naïve Bayes

True Positives
3168
3201
383

False
False
positives negatives
44
62
27
29
1686
2847
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PPV Sensitivity
98.63%
99.16%
18.51%

98.08%
99.10%
13.45%

F-score
98.35%
99.13%
15.58%

Figure 4: Validation and Training Loss, Pooled Flair Model
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Table 11: Example Classified Death Certificate Records
Death certificate tokens1
ACUTE
INTOXICATION
BY
THE
COMBINED
EFFECTS
OF
FENTANYL
,
ACETYLFENTANYL
,
METHAMPHETTAMINE
,
TRAMADOL
,
AND
GABAPENTIN
SUBSTANCE
ABUSE
MULTIPLE
DRUG
INTOXICATION
(
METHAMPHETIMINE
,
CLONAZAPAM
,
OXYCODONE
,
GABAPENTIN
)
MULTIPLE
DRUG
INTOXICATION
ACUTE
COMBINED
TOXIC
EFFECTS
OF
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Recognized by the
lookup table

Recognized by NER
model2
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,
FENTANYL
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&
PARAFLUOROBUTYRYLFENTANYL
]
SELF
ADMINISTRATION
OF
ILLICIT
DRUGS





















1. Highlighted tokens are drug entities; a horizontal line indicates the start of a new death
certificate record.
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CHAPTER 5
Discussion and Conclusions
This dissertation sought to advance surveillance science and public health practice
through examining and testing the integration of natural language processing (NLP) and
machine learning (ML) methods into the drug overdose mortality surveillance workflow.
A thorough review of the literature found that NLP and ML methods, particularly deep
learning models, are used scarcely in public health surveillance. However, evidence from
clinical sciences18,19 indicates that there is untapped potential for NLP and ML methods
to enhance public health surveillance activities. Applying NLP methods into surveillance
advances science through the tenets of integration and development24, by leveraging
techniques used primarily in other disciplines to improve understanding and stimulating
additional research in the field, respectively. The dissertation focused on advancing
surveillance practice in drug overdose mortality surveillance in particular as overdose
mortality is one of the most pressing public health crises the United States has faced in
recent history,4 with the age-adjusted drug overdose death rate increasing from 20.7 per
100,000 people in 2018 to 21.6 per 100,000 people in 20191. This dissertation presents
the development and application of two NLP models that improve drug overdose
mortality surveillance timeliness and data quality.
Enhancing timeliness
A primary limitation of drug overdose mortality surveillance is the timeliness of
the data.97 Drug overdose mortality surveillance relies on death certificates, which
become available to state and local epidemiologists after a substantial time lag
attributable to the death investigation and the process of death certificate coding at the
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National Center for Health Statistics (NCHS). Delays in obtaining data limit the ability of
practitioners to disseminate surveillance data to stakeholders as well as prohibiting timely
responses to increases in drug overdose mortality. To improve drug overdose mortality
data timeliness, Chapters 3 and 4 developed classification and named entity recognition
(NER) models, respectively, that can analyze free-text death certificate data. The
developed methods eliminate the time required to transfer death certificates between the
state Office of Vital Statistics (OVS) and the NCHS and the time for NCHS to add
International Classification of Diseases, 10th Edition16 (ICD-10) codes to the death
certificate. Utilization of the developed models in tandem to enhance currently existing
surveillance tools allows for full-scale drug overdose mortality surveillance—both case
identification and identification of drugs that caused the death—prior to ICD-10 coding.
Pre-processing of death certificates using the model developed in Chapter 3 while
records undergo ICD-10 coding allows public health practitioners to obtain provisional
counts of overdose deaths more quickly. Faster data can lead to quicker implementation
of harm reduction strategies, such as targeted naloxone distribution, thereby advancing
public health practice. Enhancing the timeliness of data through NLP also reflects an
improvement in the science of surveillance as well. According to the National Research
Council, two of the five ways in which science can be advanced is by integration (e.g.,
linking insights and methodologies from other fields and levels of analysis) and
development (e.g., stimulating additional research in the field)24. This dissertation
accomplishes both by integrating methodologies from other disciplines into public health
surveillance and by developing a base on which future scientists can build to add further
NLP methods in surveillance as described in more detail below.
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Enhancing data quality
In addition to timeliness, drug overdose mortality surveillance is also limited by
weaknesses in data quality. Death certificate data is the only national source for overdose
mortality surveillance,5 and is the primary source for state and local mortality
surveillance, making the quality of the data essential so that jurisdictions can provide
accurate information to communities, promote appropriate evidence-based practices and
policies, and monitor the impact of interventions and changes in policy. A primary data
quality limitation in drug overdose mortality surveillance is the coarse granularity of
information on what substances caused death (e.g., ICD-10 code indicates T43.6,
“psychostimulants with abuse potential” as the substance, when the specific substance
involved was methamphetamine). To address this challenge in data quality, the method
presented in Chapter 4 leverages NLP to identify novel drugs and/or drug misspellings
currently absent from lookup tables used to determine drugs involved in overdose deaths.
Chapter 4 focused on developing a state-of-the art method for identifying drug
mentions on free-text death certificate data. The developed deep learning model was able
to identify novel drugs and misspellings that look-up tables traditionally used for
performing overdose mortality surveillance were unable to identify. The developed
method improves surveillance data quality by identifying novel drugs and misspellings
on free-text death certificates that are not present in current lookup tables. These new
entities can be added to the lookup tables of existing surveillance tools.
Adding novel entities identified by the model to the lookup tables of current
surveillance tools will improve the identification of drugs on the death certificate. The
ability of the model to learn context enables it to identify novel drugs and misspellings
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that are not present in the tables currently used. This improved identification ensures that
jurisdictions are responding to the specific drugs that are causing morbidity and mortality
in a community. Many jurisdictions will not have the expertise nor the computational
power to develop and apply NLP models. Therefore, it will be necessary for centers with
the expertise to periodical run the developed deep learning model on new death
certificates, add novel entities to lookup tables, and disseminate the updated lookup tables
to jurisdictions. This process will provide increased specificity of detecting drug entities
without the need for each jurisdiction to run a complex model.
As public health initiatives rely on surveillance data, ensuring that the data is as
accurate as possible is essential. The enhancement of surveillance data quality through
the implementation of NLP methods advances public health practice by ensuring that
decisions are made on accurate, high quality data. Additionally, surveillance science is
advanced by integration (by applying techniques that emerged from a different field,
linked to previous work in clinical sciences).24 Applying NLP methods into surveillance
science are a necessity as unstructured, free-text data sources have become common in
epidemiological surveillance44,45 and the methods developed for death certificates in the
present dissertation show promise for utilization of NLP on other sources, further
advancing surveillance science through the tenet of development.24
Limitations
The contribution of this dissertation to practice and science should be interpreted
in light of its limitations. Despite the promise for NLP methods described in the narrative
review, adoption of these methods into surveillance workflows may not be possible in all
jurisdictions. Epidemiologists working in state and local public health departments may
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not have the expertise or computing infrastructure needed to implement NLP and ML
models, including those discussed in Chapters 3 and 4, in their work. However, even in
these contexts, the NER model from Chapter 4 has value. NER can be used to identify
new drug entities that can be added to look-up tables that those working in public health
currently use, allowing them to detect novel substances and identify misspellings that
were previously missing. Integrating the model presented in Chapter 4 as a tool to
improve existing drug dictionaries addresses another limitation of this method, as its use
as a stand-alone surveillance tool is limited since the entities the tool identifies must be
manually linked to a parent drug. Adding novel entities to a lookup table, which typically
contain crosswalks to parent drugs, addresses this limitation.
Another limitation is that the methods developed were trained using only data
from Kentucky death certificates. While Kentucky has a robust drug overdose mortality
surveillance system,32 thereby boosting the rigor of the analyses, it remains unknown
whether models will be generalizable outside of Kentucky. Death certificate free-text is
typically short and direct, so it is unlikely that the language used on other jurisdictions’
death certificates would differ substantially. A final limitation is the inability to diagnose
errors in the models’ performance. Complex ML models suffer from the “black box”
problem,133 which makes identifying why the model incorrectly predicted a response
difficult due to the large number of inputs and interactions present in the underlying
model.
Future research
This dissertation highlights the ability of NLP and ML models to advance public
health practice and surveillance science specifically in the context of drug overdose
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mortality surveillance. The narrative review showed that despite widespread use in
clinical sciences there was limited use of NLP methods in public health surveillance,
despite data sources including free-text elements.20 An additional gap in the use of NLP
methods in public health was the lack of state-of-the-art models used, indicating that
current advances in NLP science had not yet been translated to public health practice.
Implementing deep learning approaches in surveillance, as Chapter 4 of the dissertation
demonstrates, will improve surveillance data quality and increase case identification.
Future research in the field of drug overdose mortality surveillance should test the
developed models and develop new models on data from additional jurisdictions.
Demonstrating that the current models can accurately predict labels on data from other
jurisdictions or training a new model on data from several jurisdictions would eliminate
the current limitation of having data from only one state present. The latter would also
increase the sample size used to train the model, which typically will improve model
performance and lead to a more accurate model overall. Additionally, further
improvements can be made to the methods developed in Chapters 3 and 4. Additional
feature engineering, such as non-sequential tokens, could be explored to improve the
classification model developed in Chapter 3. The model developed in Chapter 4 could be
improved to learn additional context so that it does not identify drug entities appearing in
phrases such as “history of heroin abuse” which are not indicative that the drug was
involved in the overdose death.
Finally, there are other surveillance data sources currently used for drug overdose
mortality surveillance that contain free-text data, including emergency medical services
data44,45,131 and emergency department syndromic surveillance data.132 Studies should
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investigate the use of NLP, specifically the Flair124 library used in Chapter 4, as a tool for
information extraction and classification of these data sources. Adding NLP and ML to
the surveillance workflow for these sources will improve the quality of drug overdose
morbidity surveillance in a similar manner to how this dissertation improves the quality
of drug overdose mortality surveillance.
Conclusion
The work of the present dissertation advances the current state of surveillance
science and public health practice through the integration of NLP and ML methods that
are not currently used in the field. Integrating NLP and ML methods into the surveillance
pipeline enhances both the timeliness and quality of drug overdose mortality surveillance
data. Timely, accurate data is essential to monitoring the ongoing drug overdose
epidemic, as it ensures public health and public safety resources are directed at the
substances currently causing morbidity and mortality in communities.
The methods developed had high scores for positive predictive value, sensitivity,
and F-score. In particular, the sensitivity of the NLP methods was substantially higher
than those of currently used surveillance tools. This improved sensitivity leads to a low
false negative rate, meaning more cases that meet case criteria are identified than the
currently used text-matching methods and look-up tables. Increased case identification
allows for the collection of additional data sources in a timelier manner which can
improve the public health response to increases in overdose mortality.
NLP and ML methods are under-utilized in public health surveillance overall.
Implementation of these tools are necessary as the data collected for surveillance
purposes continues to contain free-text elements. Making accurate insights from free-text
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data is important to ensure that the public health response is based on the best available
evidence. This dissertation shows that integrating NLP and ML methods into a
surveillance workflow can lead to enhancements in both data timeliness and data quality
and provides an overall advancement to public health practice and surveillance science
through the development of two highly accurate models that ensure timely, high quality
data for drug overdose mortality surveillance.
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APPENDICES
Appendix 1: Phrase list for rule-based method
1. Overdose
2. Polypharmacy
3. Drug intoxication
4. Multiple drug
5. Combined drug
6. Acute combined
7. Intoxication drug
8. Drug toxicity
9. Acute fentanyl
10. Fentanyl intoxication
11. Fentanyl toxicity
12. Heroin intoxication
13. Multidrug intoxication
14. Heroin toxicity
15. Acute intoxication
16. Combined effects
17. Toxic effects
18. Acute heroin
19. Multi drug
20. Multiple drugs
21. Illicit drugs
22. Abused fatal
23. Heroin fentanyl
24. Intoxication fentanyl
25. Fentanyl morphine
26. Intoxication methamphetamine
27. Acute multidrug
28. Intoxication heroin
29. Illicit drug
30. Acute methamphetamine
31. Drug fentanyl
32. Drugs including
33. Gabapentin drug
34. Methamphetamine intoxication
35. Intoxication overdose
36. Drug heroin
37. Including heroin
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Appendix 2: Error analysis
The false positives and false negatives of the SVM model excluding the SCC
section were examined manually to determine if a post-processing step after the classifier
is deployed could be used to improve classification. As Table 4 of the manuscript shows,
this model had a total of 35 false positives and 21 false negatives on the test data. Of the
35 false positives, more than 10 appear to be data quality errors in the UCOD field on the
DC records. These cases have free-text that points to the death being an OD death, but the
text listed in the UCOD field is not an ICD-10 code.
Another category of the false positive cases are cases that appear to be OD deaths
that were wrongly coded at NCHS. Of these cases, several of them mention the term
“overdose” which likely lead the classifier to predict that these cases are ODs. Other
cases in this category mention the decedent dying as a result of “drug intoxication”
(listing a specific drug or indicating multiple drugs) or mention elevated levels of a
substance in the decedent’s system. Interestingly, most of the cases in these categories list
other complications, such as “asphyxiation due to drug overdose”, with NCHS then
coding the cases as an asphyxiation death. However, if the OD was an event that directly
caused the individual to asphyxiate, these deaths should perhaps be coded as OD deaths.
This presents another use for this classifier—potentially identifying additional OD deaths
that were miscoded at NCHS.
The majority of the other false positives are cases that involve deaths caused by
chronic drug abuse (not an acute OD event) or an OD exacerbating some sort of
condition or causing an injury that then leads to death. These cases include examples of
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an individual overdosing and then falling into a river and drowning, or an individual
ingesting drugs and aggravating their existing chronic obstructive pulmonary disease.
The presence of specific words, such as substances and terms like “intoxication”, likely
lead to the classifier mistaking these for OD deaths.
Many of the 21 false negatives were cases with a small amount of text that
contained substances that are rarely seen in OD deaths (such as acetaminophen) or
contain misspellings. For example, one false negative misspells “toxicity” as “tocicity”
and others misspell “drug” as “drue.” Employing an automated spell checker when
preprocessing the text may fix some of these errors. The other false negatives are the
opposite—well written text that is much longer than what typically appears on a DC.
Many of these list that the decedent died from a combination of drugs and alcohol, so the
presence of the word alcohol (or related terms such as ethanol) may signal the classifier
that the death may be an alcohol related death and not a drug OD death, resulting in
misclassification.
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Appendix 3: Flair Modeling Code

# Reading in the corpus
from flair.data import Corpus
from flair.datasets import ColumnCorpus

In [1]:

columns = {0: "text", 1: "ner"}
data_folder = "/home/pjwa227/Corpus2/"
corpus: Corpus = ColumnCorpus(data_folder, columns,
train_file = "train.txt",
test_file = "test.txt",
dev_file = "val.txt")
2020-12-11 09:17:50,035 Reading data from /home/pjwa227/Corpus2
2020-12-11 09:17:50,036 Train: /home/pjwa227/Corpus2/train.txt
2020-12-11 09:17:50,036 Dev: /home/pjwa227/Corpus2/val.txt
2020-12-11 09:17:50,036 Test: /home/pjwa227/Corpus2/test.txt

In [2]:

# Quick check
print(len(corpus.train))
print(corpus.train[1].to_tagged_string("ner"))
6108
INTRAVENTRICULAR HEMORRHAGE COUMADIN <S-DRUG> TOXICITY
# Tell flair what tag we want to predict
tag_type = "ner"
tag_dictionary = corpus.make_tag_dictionary(tag_type=tag_type)

In [3]:
In [4]:

# Load embeddings
from flair.embeddings import PooledFlairEmbeddings, StackedEmbeddings
embeddings : StackedEmbeddings =
StackedEmbeddings([PooledFlairEmbeddings("news-forward"),
PooledFlairEmbeddings("news-backward"),])
# Initialize the sequence tagger
from flair.models import SequenceTagger
tagger : SequenceTagger = SequenceTagger(hidden_size =256,
embeddings = embeddings,
tag_dictionary =
tag_dictionary,
tag_type = tag_type,
use_crf = True)
print(tagger)
SequenceTagger(
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In [5]:

(embeddings): StackedEmbeddings(
(list_embedding_0): PooledFlairEmbeddings(
(context_embeddings): FlairEmbeddings(
(lm): LanguageModel(
(drop): Dropout(p=0.05, inplace=False)
(encoder): Embedding(300, 100)
(rnn): LSTM(100, 2048)
(decoder): Linear(in_features=2048, out_features=300,
bias=True)
)
)
)
(list_embedding_1): PooledFlairEmbeddings(
(context_embeddings): FlairEmbeddings(
(lm): LanguageModel(
(drop): Dropout(p=0.05, inplace=False)
(encoder): Embedding(300, 100)
(rnn): LSTM(100, 2048)
(decoder): Linear(in_features=2048, out_features=300,
bias=True)
)
)
)
)
(word_dropout): WordDropout(p=0.05)
(locked_dropout): LockedDropout(p=0.5)
(embedding2nn): Linear(in_features=8192, out_features=8192,
bias=True)
(rnn): LSTM(8192, 256, batch_first=True, bidirectional=True)
(linear): Linear(in_features=512, out_features=8, bias=True)
(beta): 1.0
(weights): None
(weight_tensor) None
)
# Train
from flair.trainers import ModelTrainer
trainer : ModelTrainer = ModelTrainer(tagger, corpus)

In [7]:

trainer.train('resources/taggers/pooled_flair_ner',
learning_rate=0.1,
mini_batch_size=32,
max_epochs=150)
Results:
- F1-score (micro) 0.9913
- F1-score (macro) 0.9913
By class:
DRUG
tp: 3201 - fp: 27 - fn: 29 - precision: 0.9916 - recall:
0.9910 - f1-score: 0.9913
2020-12-11 09:42:20,443 --------------------------------------------------------------------------------------------------Out[7]:
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Appendix 4: Drug Overdose Fatality Surveillance System Drug Entities
25B-NBOME
25C-NBOME
25D-NBOME
25H-NBOME
25I-NBOME
3METHYLFENTANYL
3-METHYLFENTANYL
3METHYLMORPHINE
3-METHYLMORPHINE
3-METHYLTHIOFENTANYL
4_ANPP
4ANPP
4-ANPP
4-METHOXYBUTYRYLFENTANYL
5F-AB-PINACA
5F-ADB
5F-ADB-PINACA
5F-AMB
5F-NNEI
5F-PB-22
5F-THJ
6-AM
6MAM
6-MAM
6-MOMOACETYLMORPHINE
6-MONACETYLMORPHINE
6-MONOACETYLMOPRHINE
6MONOACETYLMORPHINE
6-MONOACETYLMORPHINE
6-MONOACETYMORPHINE
6-MONOACETYTMORPHINE
6-MONOACEYTLYMORPHIN
6-MONOACEYTLYMORPHINE
6-MONOACEYTLYMORPHONE
6-MONOACTEYLMORPHINE
7-AMINOCLONAZEAPM
7AMINOCLONAZEPAM

JWH-073
JWH-122
JWH-210
JWH-250
LAMOTRIGINE
LAZANDA
LEVAMISOLE
LEVETIRACETAM
LEVOFLOXACIN
LIDOCAINE
LOPERAMIDE
LORAZEPAM
LORAZEPAN
LORCET
LORTAB
LYRICA
M-144
MAB-CHMINACA
MA-CHMINACA
MAM-2201
MARIJUANA
MATRIFEN
MAXIDONE
MDMA
MDMB-CHMICA
MDMB-FUBINACA
MDPV
MDPV
MEDICATION
MEPERIDINE
MEPHEDRONE
MEPHEDRONE
MEPROBAMATE
METAHDONE
META-METHYMETHOXYACETYL FENTANYL
METAXALONE
METFORMIN
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7-AMINOCLONAZEPAM
AB-CHMINACA
AB-FUBINACA
AB-PINACA
ABSTRAL
ACETAMINOPHEN
ACETYL-ALPHA-METHYLFENTANYL
ACETYLFENTANYL
ACID
ACRYLFENTANYL
ACTIQ
ADB-FUBINACA
ADBICA
ADB-PINACA
ADDERALL
AH-7921
ALCOHOL
ALFENTANIL
ALPHA-METHYLFENTANYL
ALPHA-METHYLTHIOFENTANYL
ALPHA-PBP
ALPHA-PPP
ALPHA-PVP
ALPRAOZOLAM
ALPRAZOLAM
ALPRAZOLAN
ALPRAZOLEM
ALRPAZOLAM
AMB
AMBIEN
AMIDONE
AMINOCLONAZEPAM
AMIODARONE
AMITRIPTYLINE
AMLODIPINE
AMPHETAMINE
AMPHETAMINES
ANEXSIA
ANPP
ANTICONVULSANT
ANTICONVULSANTS
ANTIDEPRESSANT
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METH
METHADONE
METHADOSE
METHAMHPETAMINE
METHAMPHETAMINE
METHANOL
METHEDRONE
METHEDRONE
METHOCARBAMOL
METHORPHAN
METHOTREXATE
METHOXETAMINE
METHOXYACETYLFENTANYL
METHOXYBUTYRYLFENTANYL
METHYLENEDIOXYMETHAM
METHYLETHCATHINONE
METHYLETHCATHINONE
METHYLFENTANYL
METHYLONE
METHYLONE
METOCLOPRAMIDE
METONITAZENE
METOPROLOL
MIRTAZAPINE
MIRTAZEPINE
MITRAGYNINE
MN18
MO-CHMINACA
MOLLY
MOMOACETYLMORPHINE
MONACETYLMORPHINE
MONOACETYLMOPRHINE
MONOACETYLMORPHINE
MONOACETYMORPHINE
MONOACETYTMORPHINE
MONOACEYTLYMORPHIN
MONOACEYTLYMORPHINE
MONOACEYTLYMORPHONE
MONOACTEYLMORPHINE
MONOHYDROXYOXCARBAZEPINE
MONOXIDE
MOPRHINE

ANTIDEPRESSANTS
ANTIPSYCHOTICS
A-OH-ALPRAOZOLAM
A-OH-ALPRAZOLAM
A-OH-ALPRAZOLAN
A-OH-ALPRAZOLEM
A-OH-ALRPAZOLAM
A-OH-APRAZOLAM
APP-FUBINACA
APRAZOLAM
A-PVP
ATENOLOL
BACLOFEN
BARBITURATE
BARBITURATES
BENADRYL
BENZODIAEPINE
BENZODIAEPINES
BENZODIAZEPINE
BENZODIAZEPINES
BENZOS
BENZOYLECGONINE
BENZOYLECGONINE
BENZTROPINE
BETA-HYDROXY-3METHYLFENTANYL
BETA-HYDROXYFENTANYL
BETA-HYDROXYTHIOFENTANYL
BLEOMYCIN
BRORPHINE
BUPHEDRONE
BUPHEDRONE
BUPRENORFINE
BUPRENORPHINE
BUPROPION
BUPROPRION
BUSPIRONE
BUTALBITAL
BUTYLONE
BUTYLONE
BUTYRYLFENTANYL
CAFFEINE
CANNABINOIDS

MORPHINE
MORPHONE
MT-45
NALOXONE
NALTREXONE
NARCOTIC
NARCOTICS
NARCOTISM
N-DESMETHYL-TRAMADOL
NEURONTIN
NEUROSTIL
NICOTINE
NNEI
NORBUPRENORPHINE
NORCO
NORDIAZEPAM
NORDOXEPIN
NORFENTANYL
NORFLUOXETINE
NORPROPOXYPHENE
NORSERTRALINE
NORTRAMADOL
NORTRIPTYLINE
NORVENLAFAXINE
NUPENTIN
OCFENTANIL
O-DESMETHYL-TRAMADOL
OLANZAPINE
ONSOLIS
OPIATE
OPIATES
OPIOID
OPIOIDS
ORPHENADRINE
ORTHO-FLUORO FENTANYL
OXAZEAPM
OXAZEPAM
OXCARBAZEPINE
OXISET
OXYCODONE
OXYCODONE
OXYCONTIN
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CANNABIS
CARBAMAZEPINE
CARBAZEPINE
CARBON
CARFENTANIL
CARFENTANIL
CARFENTANYL
CARISOPRODOL
CARISPRODOL
CHARCOAL
CHLORDIAZEPOXIDE
CHLORIDE
CHLOROPHENYLPIPERAZINE
CHLORPHENIRAMINE
CHLORPROMAZINE
CITALOPRAM
CLOMIPRAMINE
CLONAZEPAM
CLOZAPINE
COCAETHYLENE
COCAINE
CODEINE
CODEINE
COTININE
COUMADIN
CRYSTAL
CYANIDE
CYCLOBENZAPRINE
CYCLOPROPYLFENTANYL
DAMASON-P
DARVOCET
DARVOCET
DARVON
DEMEROL
DEPRESSANT
DESIPRAMINE
DESOMORPHINE
DEXTROMETHORPHAN
DEXTROPROPOXYPHENE
DIACETYLMORPHINE
DIAMORPHINE
DIAZDEPAM

OXYCONTIN
OXYCOTIN
OXYGEN
OXYMOPHONE
OXYMORPHONE
OXYNORM
OZAZEPAM
PALLADONE
PANACET
PARA-FLUOROBUTYRYLFENTANYL
PARA-FLUOROFENTANYL
PARA-FLUOROISOBUTYRYLFENTANYL
PARA-METHYMETHOXYACETYL FENTANYL
PAROXETINE
PB-22
PENRAL
PENTEDRONE
PENTEDRONE
PENTYLONE
PERCOCET
PERCODAN
PETNYLONE
PHARMACEUTICAL
PHARMACOLOGIC
PHENCYCLIDINE
PHENOBARBITAL
PHENTERMINE
PHENYTOIN
PIPERACILLIN
POLYDRUG
POLYPHARMACY
POLYSUBSTANCE
POTASSIUM
PREGABALIN
PRESCRIPTIONS
PROMETHAZINE
PROOXYPHENE
PROPAFENONE
PROPANE
PROPANOLOL
PROPOFOL
PROPOFOL
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DIAZEPAM
DICYCLOMINE
DIFLUOROETHANE
DIGOXIN
DIHYDROCODEINE
DIHYDROCODEINONE
DIHYDROMORPHINONE
DILAUDID
DILTIAZEM
DIPHENHYDRAMINE
DISKETS
DOLOPHINE
DOXEPIN
DOXYLAMINE
DULOXETINE
DURAGESIC
DURAGESIC
DUROGESIC
EAM-2201
ECSTASY
EDDP
ENDOCET
ENDODAN
EPHEDRINE
EPHEDRINE
ESCITALOPRAM
ETHABOL
ETHANOL
ETHYLENE
ETHYLMETHCATHINONE
ETHYLMETHOCATHINONE
ETHYLONE
ETHYLONE
ETIZOLAN
ETOH
ETOMIDATE
EXALGO
FAB-144
FANATREX
FDU-PB-22
FEENTANYL
FENATNYL

PROPOSYPHENE
PROPOXIPHENE
PROPOXITENE
PROPOXPHENE
PROPOXTYPHENE
PROPOXY
PROPOXYCODONE
PROPOXYPHEN
PROPOXYPHENA
PROPOXYPHENE
PROPOXYPHERE
PROPOXYPHINE
PROPOXZPHENE
PROPRANOLOL
PROPXYPHENE
PSEUDOEPHEDRINE
PSYCHIATRIC
PX1
PX2
PX3
QUETIAPINE
REMIFENTANIL
ROXICET
ROXICODONE
ROXISET
SALICYLATE
SALICYLATES
SDB-006
SEROQUEL
SERTRALINE
SUBLIMAZE
SUBOXONE
SUBSTANCE
SUDAFED
SUFENTANIL
TEMAZEPAM
TETRAHYDROCANNABINOL
TETRAHYDROFURANFENTANYL
THC
THC-COOH
THIOFENTANYL
THJ
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FENTANIL
FENTANLY
FENTANOL
FENTANY
FENTANYL
FENTANYL
FENTATYL
FENTAYNL
FENTNAYL
FENTORA
FETANYL
FLEPHEDRONE
FLEPHEDRONE
FLUOROBUTYRYLFENTANYL
FLUOROISOBUTYRYLFENTANYL
FLUOXETINE
FLURAZEPAM
FURANYLFENTANYL
GABAPENTIN
GABAPIN
GABARONE
GABRION
GLYCOL
GRALISE
GUAIFENESIN
HALDID
HALOPERIDOL
HERION
HEROIN
HYCODAN
HYDROCADONE
HYDROCHLOROTHIAZIDE
HYDROCOCONE
HYDROCODINE
HYDROCODONE
HYDROCODONE
HYDROMORPHINE
HYDROMORPHONE
HYDROXYCHLOROQUINE
HYDROXYTHIOFENTANYL
HYDROXYZINE
HYSINGLA ER

THJ-018
THJ-2201
TIZANADINE
TOBACCO
TOLUENE
TOPIRAMATE
TRAMADAL
TRAMADOL
TRAMADONE
TRAMDOL
TRAMEDOL
TRAMELL
TRAMIDOL
TRAMODOL
TRAZADONE
TRAZODONE
TREMEDEL
TREMEDOL
TUSSINEX
TYLENOL
TYLOX
U47700
U-47700
U-49900
U-51754
UR-144
VALERYL FENTANYL
VALIUM
VALPROIC
VENLAFAXINE
VERAPAMIL
VICIDAN
VICODIN
VICODIN
WARFARIN
XANAX
XANAX
XLR-11
XLR11
XLR12
XLR-12
XYLAZINE
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IBUPROFEN
ZOHYDRO ER
INSTANYL
ZOLPIDEM
ISOPROPANOL
ZYDONE
ISOPROPYL
NALMEFENE
ISOTONITAZENE
QUININE
JWH-015
SUBLOCADE
JWH-018
SUBUTEX
JWH-019
NALBUPHINE
Appendix 5: Drug entities present in test data not in Drug Overdose Fatality
Surveillance System Table
ALPRAZOLM
HYDROCONE
METHAMPHETAMINES
ACETALFENTANYL
METHAMPHETTAMINE
IMODIUM
OYCODONE
TETRAHYDROFURANFENTANYL
FENANTYL
NORIDIAZEPAM
ACETYFENTANYL
METHAMPETAMINE
INULIN
INSULIN
ANDACETYLFENTANY
HYDORCODONE
BENZO-DIAZEPINES
INDOMETHACIN
FENTANYLN
BENZODIAZAPENIES
4-NAPP
THC COOH
OPATES
CODIENE
4-ANNP
AMPHETAIMES
METHAMPHETIMINE
CLONAZAPAM
CANNABINOID
7-AMINOCIONAZEPAM
HYDROOXYZINECAUSING

FLOUXETINE
NORFLUOXITINE
DEMOXEPAM
DESIGNER FENTANYLS
CANNABOIDS
4-AANP
ACETYLFENTAYL
DESIGNER OPOIDS
ALPRAZPOAM
BENZO
FENTANL
3,4 METHYLENEDIOXY-METHAMPHETAMINE
ALPROZOLAM
KETAMINE
METHOXYCETYFENTANYL
GAHAPENTIN
ARIPIPRAZOLE
DIPHENHYDRA
SERTALINE
VENAFLAXZINE
BENZOYLECGONINE.QUANT
NITROGLYCERIN
METHAMPHRTAMINE
CLONZEPAN
BENZODIAZIPINE
BENZODIAPINE
ZANAFLEX
METHOXYACETYLFENTANY
GGABAPENTIN
HYDROXYAINE
CONTININE
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ACETYFENTANTANYL
BUTYRYFENTANYL
TOPIRMATE
TCC-COOH
MORPINE
METHAMPH
EFFEXOR
PRISTIQ
FLEXERIL
OXMORPHONE
$-ANPP
OXYCODE
METHAPHETAMINE
1,1-DIFLUOROETHANE
TCH-COOH
DESIGNER OPIOIDS
NIFEDIPINE
ACETYL FENTANYL
AMHPETAMINE
4-AMPP
PARAFLUROBUTYRYLFENTANYL
DESPROPIONYLFENTANYL
DESIGNER OPIATE
4-ANP
OXYCODEONE
METAMPHETAMINE
4ANNP
CRACK COCAINE
OXYCODONC
GABAPCNTIN
LOPERAMITE
IMMODIUM
OVERDOSE:FENTANYL
CALCIUM CHANNEL BLOCKER

O-DESMETHYLVENLAFAXINE
MEXILETINE
NAPROXEN
FANTANYL
ACETYFENTANY
FLUXETINE
ACETLFENTANYL
ACETYFENTAN
ACETYLFENTANYL1
SODIUM NITRATE
BUSPRENORPHINE
WITHACETYLFENTANYL
COCAETHYENE
TRAZODON
HYDROX
METHANPHETAMINE
AMPHETATMINE
BENZODIAZOPINE
METHAMPHETEMINE
METHANPHETAMINES
ACETTYLFENTANYL
SODIUM NITRITE
4NAPP
ACEYLFENTANYL
METHAMPPHETAMINE
BUBRENORPHINE
METHAMPHATAMINE
METHAMPHETAMINR
DESIGNER DRUGS
GABAPENTIN_
DIIIIIAZEPAM
PARAFLUOROBUTYRYLFENTANYL
ACEYTLFENTANYL
PARA-FLUOROISOBUTYRYL FENTANYL
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